{
  "meta": {
    "title": "00016_Late_Night_Pyq_Pyt_Marathon_-_16",
    "url": "https://brainandscalpel.vercel.app/00016-late-night-pyq-pyt-marathon-16-a026ee11.html",
    "scrapedAt": "2025-11-29T17:24:31.287Z"
  },
  "questions": [
    {
      "id": 425,
      "choices": [
        {
          "id": 1696,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Protrusion</span></p>"
        },
        {
          "id": 1697,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Elevation</span></p>"
        },
        {
          "id": 1698,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 1699,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Retraction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Among the following, what is the function of the green muscles marked? (</span>AIIMS May 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-3.jpg\" alt=\"\" width=\"250\" height=\"273\"></span></p>",
      "unique_key": "Q7353321",
      "question_audio": null,
      "question_video": null,
      "map_id": 12279914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. C. Depression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p>The muscle marked in green is the lateral pterygoid muscle, and its primary function among the given options is depression of the mandible (opening the mouth). \"Depression is brought about mainly by the lateral pterygoid\" and it is \"indispensible for actively opening the mouth.\"</p><p>The lateral pterygoid has the following actions:</p><ul><li>Depression of the mandible (primary active opener of the mouth)</li><li>Protrusion of the mandible</li><li>When one side contracts, it turns the chin to the opposite side</li></ul><p>&nbsp;</p><p>While the digastric, geniohyoid, and mylohyoid muscles assist in depression, they primarily help when the mouth is opened wide or against resistance. The lateral pterygoid is the main muscle responsible for actively opening the mouth during normal function.<br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Option A. Protrusion:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:11pt;\">Protrusion refers to the forward movement of the lower jaw (mandible).</span></li><li><span style=\"font-size:11pt;\">The lateral along with medial pterygoid muscle are responsible for protruding the mandible. When this muscle contracts on both sides, it causes the jaw to move forward.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Option B. Elevation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:11pt;\">Elevation refers to the upward movement of the mandible, closing the mouth.</span></li><li><span style=\"font-size:11pt;\">The primary muscles responsible for jaw elevation are the masseter, temporalis, and medial pterygoid muscles. The lateral pterygoid's main function is not jaw elevation but rather protrusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Option D. Retraction:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:11pt;\">Retraction refers to the backward movement of the mandible.</span></li><li><span style=\"font-size:11pt;\">The primary muscles involved in jaw retraction are the temporalis and the posterior fibers of the digastric muscle. The lateral pterygoid is not primarily responsible for this movement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\"><strong>Muscles of mastication</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-172431.jpg\" alt=\"\" width=\"1000\" height=\"837\"></p>",
      "correct_choice_id": 1698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20841,
      "choices": [
        {
          "id": 83328,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Panic Disorder</span></p>"
        },
        {
          "id": 83329,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized Anxiety Disorder</span></p>"
        },
        {
          "id": 83330,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 83331,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Social Phobia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A medical student presented with complaints of repeated episodes lasting approximately 30 minutes, characterized by breathlessness, palpitations, sweating, hyperventilation, and a fear of an impending heart attack. The patient has experienced these episodes 5-6 times per month over the last 6 months, and investigations did not reveal any obvious abnormalities. What is the likely diagnosis?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q3090035",
      "question_audio": null,
      "question_video": null,
      "map_id": 12279915,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Panic Disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of a medical student with repeated episodes of breathlessness, palpitations, sweating, hyperventilation, and fear of an impending heart attack, each lasting approximately 30 minutes and occurring 5-6 times per month over the last 6 months, with no abnormalities found in investigations, is highly suggestive of <strong>Panic Disorder</strong>. Panic Disorder is characterized by recurrent, unexpected panic attacks, which are abrupt surges of intense fear or discomfort reaching a peak within minutes. The symptoms described, including palpitations, sweating, and hyperventilation, are common during panic attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Generalized Anxiety Disorder (GAD):&nbsp;</strong>GAD is characterized by persistent and excessive worry about various things, but it does not typically involve the acute, intense episodes of fear or the physical symptoms of a panic attack.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Depression:&nbsp;</strong>While depression can have anxiety symptoms and panic attacks, the primary feature is a persistent low mood and loss of interest or pleasure in activities, which is not mentioned in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Social Phobia: </strong>Also known as social anxiety disorder, this involves a significant fear of social or performance situations. The symptoms described do not specifically relate to social or performance situations, making this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Panic disorder is characterized by recurrent and unexpected panic attacks with anticipatory anxiety. Patients may start ‘avoiding’ situations that they link with the panic attack. Treatment includes a combination of pharmacotherapy [benzodiazepines for short term and SSRIs for long term] and psychotherapy [CBT, relaxation techniques] is preferred.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 12th edition, Page No 402.</strong></span></p>",
      "correct_choice_id": 83328,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44847,
      "choices": [
        {
          "id": 179035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 12 mg 24 hourly 2 doses</span></span></span></p>"
        },
        {
          "id": 179036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></span></span></p>"
        },
        {
          "id": 179037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 12 hourly 2 doses</span></span></span></p>"
        },
        {
          "id": 179038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 24 hourly 4 doses</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation: (</span></span></span>INICET May 2024)</p>",
      "unique_key": "Q4116255",
      "question_audio": null,
      "question_video": null,
      "map_id": 12279916,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For promoting fetal lung maturation in cases of threatened preterm labor, corticosteroids are administered to enhance the production of surfactant, which helps in reducing the risk of neonatal respiratory distress syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonly recommended regimens are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 12 mg intramuscularly every 24 hours for 2 doses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 6 mg intramuscularly every 12 hours for 4 doses.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given these recommendations, the correct options is:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Dexamethasone 6 mg 12 hourly 4 doses</span></span></strong></p>",
      "correct_choice_id": 179036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52369,
      "choices": [
        {
          "id": 208969,
          "text": "<p><span style=\"font-size:12.0pt;\">Deferoxamine</span></p>"
        },
        {
          "id": 208970,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated charcoal</span></p>"
        },
        {
          "id": 208971,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimercaprol</span></p>"
        },
        {
          "id": 208972,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas revealed acidosis. Which of the following can be used in the management of this condition? (Neet pg 2022)</span></p>",
      "unique_key": "Q7613841",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280488,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Deferoxamine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron overdose, particularly with ferrous sulfate tablets, can lead to severe toxicity. Ingesting more than 60 mg/kg of elemental iron is considered potentially lethal. Acute iron poisoning presents with gastrointestinal symptoms initially and can progress to metabolic acidosis, shock, and multi-organ failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of acidosis on arterial blood gas analysis is an important indicator of severe iron toxicity and an indication for the administration of an antidote. The appropriate antidote for acute iron intoxication is&nbsp;<strong>deferoxamine</strong>. Deferoxamine chelates free iron, forming a water-soluble complex that is excreted in the urine, thereby reducing iron's toxic effects on the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Activated charcoal:&nbsp;</strong>Activated charcoal is not effective in cases of iron poisoning. It does not adsorb metals like iron and can be harmful in certain situations like heavy metal poisoning, alcohols, petroleum products, and caustic substances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Dimercaprol:&nbsp;</strong>Dimercaprol is used for chelation therapy in heavy metal poisoning (e.g., arsenic, mercury, gold) but is not effective for iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Penicillamine:&nbsp;</strong>Penicillamine is another chelating agent, typically used for conditions such as Wilson's disease (copper overload) and rheumatoid arthritis. It is not effective in treating iron toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of acute iron intoxication with signs of toxicity such as acidosis, the antidote of choice is deferoxamine. Activated charcoal is not effective in iron poisoning and should not be used.</span></p>",
      "correct_choice_id": 208969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9980,
      "choices": [
        {
          "id": 39886,
          "text": "<p><span style=\"font-size:12.0pt;\">CRISPR</span></p>"
        },
        {
          "id": 39887,
          "text": "<p><span style=\"font-size:12.0pt;\">Big data</span></p>"
        },
        {
          "id": 39888,
          "text": "<p><span style=\"font-size:12.0pt;\">Gene Xpert</span></p>"
        },
        {
          "id": 39889,
          "text": "<p><span style=\"font-size:12.0pt;\">GWAS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a tool used in gene editing:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p>",
      "unique_key": "Q4908904",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280489,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CRISPR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The core technologies now most commonly used to facilitate genome editing are -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) – CRISPs are guide RNAS. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added in vivo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/61.jpg\" alt=\"\" width=\"676\" height=\"489\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. Transcription activator-like effector nucleases (TALENs)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. Zinc-finger nucleases (ZFNs)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4. Homing endonucleases or meganucleases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Big data</strong>: Refers to the large volume of data that can be analyzed to reveal patterns, trends, and associations, especially relating to human behavior and interactions, but it is not a tool for gene editing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Gene Xpert</strong>: Is a diagnostic tool used to detect genetic material from specific pathogens (e.g., Mycobacterium tuberculosis) and is not related to gene editing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. GWAS (Genome-Wide Association Studies)</strong>: Involves scanning genomes from many different people to find genetic markers associated with specific diseases. While related to genetics, it is not a tool for directly editing genes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRISPR is a powerful gene editing tool that enables precise modifications of the genome and is used extensively in genetic research and therapeutic applications.</span></p>",
      "correct_choice_id": 39886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24393,
      "choices": [
        {
          "id": 97533,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 97534,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 97535,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 97536,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">La belle indifference is seen in which of the following conditions?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q1060042",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280490,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Conversion disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">La Belle indifference can be seen in Conversion disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>CONVERSION DISORDER</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ICD-11 uses the term ‘dissociative neurological symptom disorder’</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Patients present with symptoms suggestive of motor, sensory or cognitive deficits; however, no neurological cause can be found.</span></li><li><span style=\"font-size:12.0pt;\">Also, the symptoms do not conform to the anatomical and physiological principles</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients may have ‘la belle indifference’, which is a lack of concern for the symptoms. E.g., A patient with sudden onset loss of vision in an eye may appear unconcerned with her symptom.</span></p>",
      "correct_choice_id": 97536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6150,
      "choices": [
        {
          "id": 24569,
          "text": "<p><span style=\"font-size:12.0pt;\">Countertransference</span></p>"
        },
        {
          "id": 24570,
          "text": "<p><span style=\"font-size:12.0pt;\">Transference</span></p>"
        },
        {
          "id": 24571,
          "text": "<p><span style=\"font-size:12.0pt;\">Dissociation</span></p>"
        },
        {
          "id": 24572,
          "text": "<p><span style=\"font-size:12.0pt;\">Preoccupation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">During psychotherapy, the therapist had mixed conscious and unconscious feelings towards his patient. This is known as?&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q2466250",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280491,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Countertransference</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Countertransference refers to the therapist's emotional reactions, both conscious and unconscious, towards a patient, often influenced by the therapist's own past.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Transference:</strong>&nbsp;Transference is when the patient unconsciously redirects feelings experienced in an earlier relationship to the therapist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Dissociation:</strong>&nbsp;Dissociation is a disconnection and lack of continuity between thoughts, memories, surroundings, actions, and identity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Dissociation:&nbsp;</strong>Preoccupation is being absorbed in thought, typically about something particular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transference refers to the redirection of a patient's feelings and attitudes from past experiences or individuals onto the therapist, typically operating on an unconscious level. Countertransference represents the therapist's emotional reactions to a patient, both conscious and unconscious. These reactions may be influenced by the therapist's own personal history, unresolved conflicts, or reactions to the patient's transference.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan and Sadock’s Synopsis of Psychiatry, 12th edition, Page No 1069</strong></span></p>",
      "correct_choice_id": 24569,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6835,
      "choices": [
        {
          "id": 27309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH</span></span></span></p>"
        },
        {
          "id": 27310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin</span></span></span></p>"
        },
        {
          "id": 27311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin</span></span></span></p>"
        },
        {
          "id": 27312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GH</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following hormones play a permissive role in the attainment of puberty? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q5044655",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280492,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Leptin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hormone that plays a permissive role in the attainment of puberty is leptin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin is a peptide hormone released from adipocytes</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin plays an important role in controlling the adipose tissue and food intake. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Actions of leptin:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acts on hypothalamus and inhibits the feeding center, resulting in stoppage of food intake</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stimulates the metabolic reactions involved in utilization of fat stored in adipose tissue for energy. Thus, the circulating leptin level informs the brain about the energy storage and the necessity to regulate metabolic reactions, food intake and body weight</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated leptin levels might have a permissive effect on the pubertal process and pubertal growth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. GnRH:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as GnRH directly stimulates the secretion of LH and FSH, which are critical for puberty but not considered permissive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Insulin:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While it plays a supportive role in general growth and development, it is not specifically permissive for the onset of puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. GH:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Growth hormone is vital for growth and development during puberty but does not have a direct permissive role in the initiation of puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leptin serves a permissive role in puberty, indicating to the hypothalamus that sufficient energy reserves are available for the safe progression of reproductive development. This hormone essentially &quot;permits&quot; the initiation of puberty when energy conditions are met.</span></span></span></p>",
      "correct_choice_id": 27310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32735,
      "choices": [
        {
          "id": 130790,
          "text": "<p><span style=\"font-size:12pt;\">Glycolytic pathway</span></p>"
        },
        {
          "id": 130791,
          "text": "<p><span style=\"font-size:12pt;\">Pentose Phosphate pathway</span></p>"
        },
        {
          "id": 130792,
          "text": "<p><span style=\"font-size:12pt;\">Kreb’s cycle</span></p>"
        },
        {
          "id": 130793,
          "text": "<p><span style=\"font-size:12pt;\">Purine salvage pathway</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which Biochemical method is exploited for monoclonal antibody production by hybridoma technique?&nbsp; (</span>INICET Nov 2023)</p>",
      "unique_key": "Q7998023",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280643,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Purine salvage pathway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hybridoma technology → common methods used to produce monoclonal antibodies</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this process, antibody-producing B-lymphocytes are isolated from mice after immunizing the mice with specific antigen and are fused with immortal myeloma cell lines to form hybrid cells, called hybridoma cell lines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/20.png\" alt=\"\" width=\"500\" height=\"557\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Even the most efficient fusion method will give only 1 to 2% of fused and viable hybridoma cells.</span></li><li><span style=\"font-size:12pt;\">Hybridoma selection involve screening of the fused cells from the unfused cells. It is done using HAT media (a selection media).</span></li><li><span style=\"font-size:12pt;\">HAT medium contains&nbsp;Hypoxanthine-Aminopterin-Thymidine. The trick is that Aminopterin inhibits DHFR. So, it inhibits de-novo purine synthesis. Inhibition of DHFR also inhibits conversion of dUMP to dTMP.</span></li><li><span style=\"font-size:12pt;\">Salvage pathway will occur, but only in B-cells, not myeloma cells. Myeloma cells are deficient in HGPRT .</span></li><li><span style=\"font-size:12pt;\">Hypoxanthine and deoxythymidine allow cells with functional hypoxanthine-guanine phosphoribosyltransferase (HGPRT) genes to survive through salvage pathways.</span></li><li><span style=\"font-size:12pt;\">Due to a limited life span, unfused B cells perish within a few days.</span></li><li><span style=\"font-size:12pt;\">Unfused malignant neoplastic cells die as a result of the lack of HGPRT gene</span></li><li><span style=\"font-size:12pt;\">Therefore, the remaining viable cells left in the media are the hybrid cells; these hybrid cells have the ability to grow and divide on HAT media because they have functional HGPRT gene from B lymphocytes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Glycolytic pathway:&nbsp;</strong>This pathway is involved in the breakdown of glucose to pyruvate for energy production and is not specifically exploited in hybridoma technology for monoclonal antibody production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pentose Phosphate pathway:&nbsp;</strong>This pathway generates NADPH and ribose-5-phosphate for nucleotide synthesis but is not the key pathway exploited in the hybridoma technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Kreb’s cycle:&nbsp;</strong>This cycle is part of cellular respiration and energy production but is not directly involved in the selection process of hybridoma cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The purine salvage pathway is critical in hybridoma technology for monoclonal antibody production, enabling the selection of viable hybridoma cells in HAT medium.</span></p>",
      "correct_choice_id": 130793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5669,
      "choices": [
        {
          "id": 22648,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">191</span></span></span></p>"
        },
        {
          "id": 22649,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">192</span></span></span></p>"
        },
        {
          "id": 22650,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">193</span></span></span></p>"
        },
        {
          "id": 22651,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">197</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which Section of the IPC deals with the punishment of perjury?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> (NEET PG 2020)</span></span></span></p>",
      "unique_key": "Q6819444",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280644,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 193 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perjury (false evidence) means intentional making of a false statement by a person who was under a legal obligation (e.g. under oath) to speak the truth. (BNS 229)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 191: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defines the act of giving false evidence under oath. (BNS 227)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 192: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deals with the fabrication of false evidence. (BNS 228)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 197: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deals with issuing false certificates and provides the same punishment as perjury, up to 7 years. (BNS 234)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important IPC related to false evidence:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">191 IPC:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Definition of Perjury (false evidence): Giving false evidence under oath </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">193 IPC:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Punishment for Perjury (false evidence): up to 7 years</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">197 IPC:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Issuing false certificates- same punishment as that of false evidence (up to 7 years)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">201 IPC:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Causing disappearance of evidence of offence, or giving false information to screen offender: Upto 7 years. (BNS 238)</span></span></span></span></p>",
      "correct_choice_id": 22650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56824,
      "choices": [
        {
          "id": 226689,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Crescent formation</span></span></span></p>"
        },
        {
          "id": 226690,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Mesangial cell proliferation</span></span></span></p>"
        },
        {
          "id": 226691,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">IgA deposition</span></span></span></p>"
        },
        {
          "id": 226692,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of foot processes</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most consistent histological feature in cases of rapidly progressing glomerulonephritis (RPGN).&nbsp;(AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q3299004",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280645,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Crescent formation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The hallmark feature of rapidly progressive glomerulonephritis (RPGN) is the formation of crescents in the glomeruli. These crescents, composed of proliferating parietal epithelial cells and infiltrating leukocytes within the Bowman&#39;s capsule, signify severe glomerular injury. This morphological change is the primary indicator of RPGN, reflecting rapid and severe impairment of renal function. The presence of crescents typically indicates a dire prognosis, often correlating with swift progression to renal failure if not adequately treated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/2.jpg\" style=\"height:198px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option b. Mesangial cell proliferation is common in various glomerulonephritides but not a definitive feature of RPGN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option c. IgA deposition characterizes IgA nephropathy, which may progress but not typically as rapidly as crescentic RPGN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option d. Loss of foot processes is seen in minimal change disease and other causes of nephrotic syndrome, rather than primarily in RPGN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objectives:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Crescent formation in the glomeruli is the distinguishing and most consistent feature in rapidly progressive glomerulonephritis, indicating severe and swift progression of renal damage.</span></span></span></p>",
      "correct_choice_id": 226689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6043,
      "choices": [
        {
          "id": 24142,
          "text": "<p><span style=\"font-size:12pt;\">Starts after peak of uterine contraction and ends after uterine contraction ends</span></p>"
        },
        {
          "id": 24143,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿They are smooth and gradual</span></p>"
        },
        {
          "id": 24144,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿At least 10 beats, 2 times in a 20 min period above baseline</span></p>"
        },
        {
          "id": 24145,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Not associated with accelerations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which statement is false regarding late decelerations?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q5076944",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) At least 10 beats, 2 times in a 20 min period above baseline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Incorrect. Late decelerations are defined by a decrease in fetal heart rate that is typically more than 15 beats per minute below the baseline and is not defined by a specific frequency above baseline. The characteristic depth and timing of the deceleration are more important than the number of beats or frequency above the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Late decelerations in fetal heart rate patterns are important indicators of fetal well-being and uteroplacental function. late decelerations are indicative of uteroplacental insufficiency. Understanding their characteristics is crucial for accurate assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Starts after peak of uterine contraction and ends after uterine contraction ends:</strong> Correct. Late decelerations start after the peak of the uterine contraction and end after the contraction has concluded. This delayed onset and resolution are key features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. They are smooth and gradual:</strong> Correct. Late decelerations are characterized by a smooth and gradual decline in fetal heart rate (FHR).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Not associated with accelerations:</strong> Correct. Late decelerations are not typically associated with accelerations. This differentiates them from other types of decelerations, such as early decelerations, which can be accompanied by accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Late decelerations are characterized by a smooth, gradual decline in fetal heart rate that begins after the peak of a uterine contraction and returns to baseline after the contraction ends, and they are not defined by beats above baseline or associated with accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 693, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5174,
      "choices": [
        {
          "id": 20669,
          "text": "<p><span style=\"font-size:12.0pt;\">HSV</span></p>"
        },
        {
          "id": 20670,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus</span></p>"
        },
        {
          "id": 20671,
          "text": "<p><span style=\"font-size:12.0pt;\">Picornavirus</span></p>"
        },
        {
          "id": 20672,
          "text": "<p><span style=\"font-size:12.0pt;\">Parvovirus B19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Viral infection mimicking erythroblastosis fetalis is: (NEET PG 2019)</span></p>",
      "unique_key": "Q1372344",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280687,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Parvovirus B19</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 infection can mimic erythroblastosis fetalis due to its ability to infect erythroid progenitor cells and inhibit erythropoiesis, leading to severe anemia. Erythroblastosis fetalis typically results from maternal antibodies targeting fetal red blood cells, causing hemolysis and severe anemia; Parvovirus B19 causes a similar effect through a direct infection of the erythroid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 is associated with:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Erythema infectiosum (fifth disease)</span></li><li><span style=\"font-size:12.0pt;\">Transient aplastic crisis</span></li><li><span style=\"font-size:12.0pt;\">Pure red cell aplasia</span></li><li><span style=\"font-size:12.0pt;\">Erythroblastosis fetalis (most commonly in early pregnancy)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythema infectiosum rash :</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_rdNBJcg.jpg\" alt=\"\" width=\"400\" height=\"210\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. HSV (Herpes Simplex Virus):</strong> Incorrect, as HSV does not typically cause the hematologic manifestations associated with erythroblastosis fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Epstein-Barr Virus (EBV):</strong> Incorrect, while EBV can cause hematological disturbances, it does not mimic erythroblastosis fetalis but is more associated with conditions like infectious mononucleosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Picornavirus:</strong> Incorrect, this group of viruses, which includes enteroviruses and rhinoviruses, does not produce hematological symptoms that mimic erythroblastosis fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 infection can uniquely mimic erythroblastosis fetalis by causing severe fetal anemia and related complications through its direct impact on erythroid progenitor cells. Awareness of this potential complication is essential, particularly in pregnant women, as the infection can lead to significant fetal outcomes, necessitating careful monitoring and management.</span></p>",
      "correct_choice_id": 20672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2159,
      "choices": [
        {
          "id": 8625,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthritis</span></p>"
        },
        {
          "id": 8626,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann Pick disease</span></p>"
        },
        {
          "id": 8627,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer's disease</span></p>"
        },
        {
          "id": 8628,
          "text": "<p><span style=\"font-size:12.0pt;\">Cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Glucosamines are used in which of the following conditions? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q7074952",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Arthritis</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Glucosamine and chondroitin sulphate</strong> are used in the treatment of <strong>arthritis</strong> which is a degenerative joint disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucosamines are amino sugars. Mucopolysaccharides or glycosamino glycans (GAG) are <strong>heteropolysaccharides, containing uronic acid and amino sugars</strong>. Acetylated amino groups, sulfate and carboxyl groups are also generally present. Because of the presence of these charged groups, <strong>they attract water molecules and so they produce viscous solutions</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples of mucopolysaccharides are hyaluronic acid, heparin, chondroitin sulfate, dermatan sulfate and keratan sulfate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-170736.jpg\" alt=\"\" width=\"1000\" height=\"362\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Niemann-Pick disease</strong>: This is a lysosomal storage disorder caused by the accumulation of sphingomyelin, not treated with glucosamines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Alzheimer's disease</strong>: This neurodegenerative condition involves the accumulation of amyloid plaques and neurofibrillary tangles. Glucosamines are not used in its treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cancer</strong>: Cancer treatment involves a wide range of therapies such as chemotherapy, radiation therapy, and immunotherapy. Glucosamines are not used in cancer treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucosamine is used in the treatment of arthritis due to its role in maintaining healthy cartilage and joint function.</span></p>",
      "correct_choice_id": 8625,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14389,
      "choices": [
        {
          "id": 57517,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, assisted drainage, and MRI</span></p>"
        },
        {
          "id": 57518,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids, MRI, assisted drainage, and laparotomy</span></p>"
        },
        {
          "id": 57519,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, and assisted drainage</span></p>"
        },
        {
          "id": 57520,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, assisted drainage, MRI, and laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following steps are included in the management of acute necrotizing pancreatitis in a patient with large intra-abdominal fluid accumulation and pancreatic necrosis? &nbsp;(INICET NOV 2022)</span></p>",
      "unique_key": "Q2420598",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280689,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IV antibiotics, IV fluids, culture, and assisted drainage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MRI is not indicated in patients with acute necrotising pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct steps in the management of acute necrotizing pancreatitis include IV antibiotics, IV fluids, culture, and assisted drainage. Large intra-abdominal fluid accumulation and pancreatic necrosis are complications of acute pancreatitis that require immediate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aggressive fluid resuscitation, pain control, and early nutrition are initiated, followed by contrast-enhanced computed tomography to diagnose necrosis. If infected necrosis is suspected, fine-needle aspiration is done, and the aspirate is subjected to Gram staining and culture sensitivity. IV antibiotics are started with carbapenem as the first-choice drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The step-up approach, which includes percutaneous drainage followed by minimally invasive video-assisted retroperitoneal debridement, is adopted for definitive management. Hence, the correct option is C) IV antibiotics, IV fluids, culture, and assisted drainage.</span></p>",
      "correct_choice_id": 57519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56825,
      "choices": [
        {
          "id": 226693,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cardiac CT</span></span></span></p>"
        },
        {
          "id": 226694,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Viral serology</span></span></span></p>"
        },
        {
          "id": 226695,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Endomyocardial biopsy</span></span></span></p>"
        },
        {
          "id": 226696,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoantibody testing</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 45-year-old male presents to the emergency department with a 2-week history of chest pain, shortness of breath, and fatigue. His symptoms began after a recent viral illness. Physical examination reveals elevated jugular venous pressure, mild pedal edema, and muffled heart sounds. An ECG shows nonspecific ST-T wave changes, and echocardiography reveals mild left ventricular dysfunction. The patient is suspected of having myocarditis<strong>. </strong>What is the most accurate diagnostic test for confirming myocarditis?</span></span></span></p>",
      "unique_key": "Q4626976",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280740,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer. C. Endomyocardial biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Endomyocardial biopsy is the gold standard diagnostic test for myocarditis, providing direct histological evidence of myocardial inflammation. It allows for the identification of inflammatory cell infiltrates, myocyte degeneration, and necrosis, which are characteristic findings of active myocarditis. This procedure is critical in distinguishing myocarditis from other conditions that cause similar symptoms and can help determine the underlying etiology, guiding appropriate management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option A. Cardiac CT:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cardiac CT is primarily used to assess coronary anatomy and is not typically used to diagnose myocarditis. While it can show structural abnormalities and rule out coronary artery disease, it lacks the capability to detect myocardial inflammation, making it unsuitable for confirming myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option B. Viral serology:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Viral serology can detect antibodies against specific viral pathogens that may cause myocarditis; however, it does not confirm the presence of myocarditis in the heart tissue. Serological testing is not specific or sensitive enough to diagnose myocarditis, as many individuals may have positive antibodies without active myocardial inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option D. Autoantibody testing:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Autoantibody testing can be helpful in diagnosing autoimmune conditions that may lead to myocarditis, such as lupus or rheumatoid arthritis. However, it does not provide a direct assessment of myocardial inflammation or damage, making it an indirect and non-specific method for diagnosing myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Endomyocardial biopsy is the definitive diagnostic test for myocarditis, allowing direct histological examination of myocardial tissue to confirm inflammation and differentiate between various etiologies. Non-invasive tests like cardiac CT, viral serology, and autoantibody testing are not specific enough for diagnosis, highlighting the importance of biopsy in cases where accurate identification of myocardial inflammation is necessary.</span></span></span></p>",
      "correct_choice_id": 226695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11068,
      "choices": [
        {
          "id": 44238,
          "text": "<p><span style=\"font-size:18px;\">Screening for cervical cancer</span></p>"
        },
        {
          "id": 44239,
          "text": "<p><span style=\"font-size:18px;\">Providing services for unmarried mothers</span></p>"
        },
        {
          "id": 44240,
          "text": "<p><span style=\"font-size:18px;\">Screening for HIV infection</span></p>"
        },
        {
          "id": 44241,
          "text": "<p><span style=\"font-size:18px;\">Providing adoption services</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 24-year-old woman visits a clinic in Mumbai for a consultation about family planning. She discusses various options and services with her healthcare provider. During the conversation, she asks about additional health screenings included in family planning services. Which of the following screenings is NOT typically included as part of family planning services in India? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
      "unique_key": "Q6041994",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280921,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Screening for HIV infection</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Family planning services aim to support individuals and couples in managing their reproductive health, but not all health screenings are integrated into these services:</span></li><li><span style=\"font-size:18px;\"><strong>Screening for HIV infection:</strong> This screening, while crucial for overall health and particularly important in prenatal care to prevent mother-to-child transmission, is generally conducted as part of broader sexual health services rather than within the narrower scope of family planning services.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Screening for cervical cancer:</strong> This is typically included because it directly relates to reproductive health and can impact a woman’s long-term health and fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Providing services for unmarried mothers:</strong> This includes counseling and support, reflecting a comprehensive approach to reproductive health care that supports all individuals, regardless of marital status.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Providing adoption services:</strong> Part of family planning services that helps individuals and couples prepare for parenthood, including the option of adoption, aligning with the broad goals of family planning.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Family planning is not synonymous with birth control only. A WHO Expert Committee (1970) recommends that family planning includes in its’ purview:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Proper spacing and limitation of birth</span></li><li><span style=\"font-size:18px;\">Advice on sterility</span></li><li><span style=\"font-size:18px;\">Education for parenthood</span></li><li><span style=\"font-size:18px;\">Sex education</span></li><li><span style=\"font-size:18px;\">Screening for pathological conditions related to the reproductive system (e.g., cervical cancer)</span></li><li><span style=\"font-size:18px;\">Genetic counselling</span></li><li><span style=\"font-size:18px;\">Premarital consultation and examination</span></li><li><span style=\"font-size:18px;\">Pregnancy tests</span></li><li><span style=\"font-size:18px;\">Marriage counselling</span></li><li><span style=\"font-size:18px;\">Preparation of couples for the first child</span></li><li><span style=\"font-size:18px;\">Providing services to unmarried mothers</span></li><li><span style=\"font-size:18px;\">Teaching home economics and nutrition</span></li><li><span style=\"font-size:18px;\">Providing adoption services</span></li></ul>",
      "correct_choice_id": 44240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11530,
      "choices": [
        {
          "id": 46086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART if CD4 &lt;200</span></span></span></p>"
        },
        {
          "id": 46087,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART and then ATT after 2 weeks</span></span></span></p>"
        },
        {
          "id": 46088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and then ART after 2 weeks</span></span></span></p>"
        },
        {
          "id": 46089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and ART simultaneously</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newly diagnosed HIV patient presented with fever, cough, and hemoptysis. His sputum sample showed acid-fast bacilli. What is the appropriate management for this patient? (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q1357664",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280922,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Start ATT and then ART after 2 weeks</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with tuberculosis (TB), it is crucial to start antitubercular therapy (ATT) first to reduce the mycobacterial load before initiating antiretroviral therapy (ART). This approach helps to avoid immune reconstitution inflammatory syndrome (IRIS), a life-threatening condition due to massive cytokine response triggered by a rapid increase in CD4 count., which can occur if ART is started too early. The general recommendation is to start ART by 2 weeks -2 months, after ATT initiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Starting ART only if CD4 &lt;200:</strong> does not address the immediate need for TB treatment. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Starting ART before ATT</strong>: can lead to IRIS. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Starting both therapies simultaneously: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;increases the risk of IRIS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with TB, start ATT first and then initiate ART after 2 weeks-2 months duration.</span></span></span></p>",
      "correct_choice_id": 46088,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14629,
      "choices": [
        {
          "id": 58477,
          "text": "<p><span style=\"font-size:12.0pt;\">9%</span></p>"
        },
        {
          "id": 58478,
          "text": "<p><span style=\"font-size:12.0pt;\">18%</span></p>"
        },
        {
          "id": 58479,
          "text": "<p><span style=\"font-size:12.0pt;\">27%</span></p>"
        },
        {
          "id": 58480,
          "text": "<p><span style=\"font-size:12.0pt;\">36%</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Calculate the percentage of burns in a 6-year-old child whose head and neck was burnt in an accident at school? (NEET PG 2022)</span></p>",
      "unique_key": "Q8592541",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280923,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 18%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">As per Lund and Browder chart the percentage of burns in this child would be 18%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For the 1-9 years age group, the Lund-Browder chart is divided into the following regions:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Head and Neck: 18%</span></li><li><span style=\"font-size:12pt;\">Anterior Trunk: 18%</span></li><li><span style=\"font-size:12pt;\">Posterior Trunk: 18%</span></li><li><span style=\"font-size:12pt;\">Each Arm: 9%</span></li><li><span style=\"font-size:12pt;\">Each Leg: 14%</span></li><li><span style=\"font-size:12pt;\">Perineum: 1%</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Lund-Browder chart is a tool used to estimate the total body surface area (TBSA) of burns in paediatric patients. It is divided into regions that correspond to different percentages of TBSA, and each region is assigned a different percentage based on the age of the patient. The chart takes into account the fact that the proportion of body surface area represented by different body parts changes as a child grows.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The chart is divided into three age groups: 0-1 year, 1-9 years, and 9-17 years. Each age group has its own chart with different regions and percentages. The regions are further divided into sub-regions to allow for more accurate estimation of the TBSA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 9%:&nbsp;</strong>For a 6-year-old child, 9% represents the TBSA of each arm. This does not correspond to the head and neck region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 27%:&nbsp;</strong>There is no single region in the Lund-Browder chart for the 1-9 years age group that accounts for 27% of the TBSA. The head and neck alone are 18%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 36%:&nbsp;</strong>This percentage does not correspond to any single region or combination of the head and neck in the Lund-Browder chart for a child of this age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Understanding the Lund and Browder chart is essential for accurately assessing burn injuries in pediatric patients.</span></li><li><span style=\"font-size:12pt;\">For children aged 1-9 years, the head and neck region accounts for 18% of the TBSA.</span></li><li><span style=\"font-size:12pt;\">This knowledge is crucial for determining the appropriate treatment and management of burn injuries in children.</span></li></ul>",
      "correct_choice_id": 58478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43953,
      "choices": [
        {
          "id": 175475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Fluoroscein isothiocyanate</span></span></span></p>"
        },
        {
          "id": 175476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Alkaline phosphatase</span></span></span></p>"
        },
        {
          "id": 175477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Diamino benzidene</span></span></span></p>"
        },
        {
          "id": 175478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Benzene</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following stains cause brown color to Her 2 neu cells of breast carcinoma as shown in the image?&nbsp;(INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-172631.JPG\" style=\"height:223px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q3263246",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280924,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Ans. C) Diamino benzidene</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diaminobenzidine (DAB) is commonly used as a chromogen in immunohistochemistry. It reacts with the peroxidase enzyme in a substrate solution, producing a brown precipitate that is visible under a microscope, marking the antigen-antibody binding site.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Fluorescein Isothiocyanate:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a fluorochrome and not used for color development in traditional histopathological stains, but rather for fluorescence microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Alkaline Phosphatase:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This enzyme can be used in immunohistochemistry, typically resulting in red or blue stains, depending on the substrate used, not brown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Benzene:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is an organic solvent and not used as a chromogen in histopathology or immunohistochemistry.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For staining specific proteins like Her2 in breast carcinoma tissues, diaminobenzidine (DAB) is a preferred chromogen for peroxidase-mediated reactions in immunohistochemistry, yielding a distinct brown coloration which highlights the presence of the target antigen.</span></span></span></p>",
      "correct_choice_id": 175477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10102,
      "choices": [
        {
          "id": 40374,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
        },
        {
          "id": 40375,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial sarcoma</span></p>"
        },
        {
          "id": 40376,
          "text": "<p><span style=\"font-size:12.0pt;\">Ewing sarcoma</span></p>"
        },
        {
          "id": 40377,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammatory myofibroblastic tumour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">ALK positivity is seen in which of the following neoplasms: </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q6809770",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Inflammatory myofibroblastic tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALK (anaplastic lymphoma kinase) is seen in Inflammatory myofibroblastic tumor of lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(ALK) Anaplastic lymphoma kinase {<strong>CD246</strong>} is a tyrosine kinase receptor encoded by the ALK gene located on <strong>chromosome 2p</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALK positive tumors respond to ALK kinase inhibitors, therefore it has an <strong>excellent prognosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fibromatosis</strong>: ALK positivity is not associated with fibromatosis. This condition is characterized by fibroblastic proliferation, and ALK is not typically involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Synovial sarcoma</strong>: Synovial sarcoma does not show ALK positivity. It is more often associated with specific translocations, such as <strong>t(X;18)(p11;q11)</strong>, resulting in SS18-SSX fusion genes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ewing sarcoma</strong>: Ewing sarcoma is characterized by a specific <strong>EWSR1-FLI1 fusion gene</strong> due to a translocation involving chromosomes 11 and 22. ALK positivity is not seen in Ewing sarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ALK positivity is seen in:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lung Cancers – Adenocarcinoma</strong>, small cell cancer, anaplastic cancer</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inflammatory myofibroblastic tumor</strong></span></li><li><span style=\"font-size:12.0pt;\">Neuroblastoma</span></li><li><span style=\"font-size:12.0pt;\">Renal cell carcinomas</span></li><li><span style=\"font-size:12.0pt;\">Esophageal squamous cell carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Breast cancer notably the inflammatory subtype</span></li><li><span style=\"font-size:12.0pt;\">Colonic adenocarcinoma</span></li><li><span style=\"font-size:12.0pt;\">Glioblastoma multiforme</span></li><li><span style=\"font-size:12.0pt;\">Anaplastic thyroid cancer</span></li></ul>",
      "correct_choice_id": 40377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7119,
      "choices": [
        {
          "id": 28444,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The inhibitor can bind with any site resulting in suicidal inhibition</span></span></span></p>"
        },
        {
          "id": 28445,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The binding of the enzyme to the substrate analogue is irreversible</span></span></span></p>"
        },
        {
          "id": 28446,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are enzyme specific and used in rational drug design</span></span></span></p>"
        },
        {
          "id": 28447,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The inhibitor forms a product with the enzyme and the product inhibits it</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the false statement regarding suicidal inhibition? (</span></span>INICET Nov 2021)</p>",
      "unique_key": "Q9920158",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. The inhibitor can bind with any site resulting in suicidal inhibition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SUICIDE INHIBTION </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Suicide inhibition, also known as mechanism-based inhibition, is a unique and fascinating aspect of enzyme kinetics. It&#39;s a process where an enzyme binds to a substrate analogue, which initially seems like a normal substrate to the enzyme. However, as the enzyme starts to act on this &#39;pseudo-substrate,&#39; a chemical reaction occurs that modifies the enzyme in such a way that it becomes irreversibly inactivated. This process is termed &#39;suicide&#39; because the enzyme actively participates in its own inhibition.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">STEPS INVOLVED IN SUICIDE INHIBITION</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Binding:</span></strong><span style=\"font-size:12.0pt\"> The suicide substrate, which is often structurally similar to the actual substrate, binds to the enzyme&#39;s active site.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Initial Reaction:</span></strong><span style=\"font-size:12.0pt\"> The enzyme catalyses a reaction on this substrate analogue, similar to how it would act on its natural substrate.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Formation of Reactive Intermediate:</span></strong><span style=\"font-size:12.0pt\"> This reaction, however, leads to the formation of a chemically reactive intermediate. This intermediate is the key to the suicide inhibition mechanism.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification of Enzyme:</span></strong><span style=\"font-size:12.0pt\"> The reactive intermediate then reacts with the enzyme itself, leading to a covalent modification of the enzyme. This modification typically occurs at the active site, crucial for the enzyme&#39;s activity.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Irreversible Inhibition:</span></strong><span style=\"font-size:12.0pt\"> As a result of this modification, the enzyme is irreversibly inactivated. It can no longer bind to its natural substrate or catalyse the reaction it was designed for.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Specificity:</span></strong><span style=\"font-size:12.0pt\"> One of the key features of suicide inhibition is its specificity. Because the inhibitor is structurally similar to the natural substrate, the process is highly specific to the targeted enzyme. This makes suicide inhibitors very effective as drugs, as they can selectively target and inactivate specific enzymes in the body.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;B. The binding of the enzyme to the substrate analogue is irreversible</span></strong><span style=\"font-size:12.0pt\">: This is true. The substrate analogue binds irreversibly to the enzyme, leading to its permanent inactivation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. They are enzyme specific and used in rational drug design</span></strong><span style=\"font-size:12.0pt\">: This is true. Suicide inhibitors are designed to be highly specific for the target enzyme, making them valuable in rational drug design.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The inhibitor forms a product with the enzyme and the product inhibits it</span></strong><span style=\"font-size:12.0pt\">: This is true. The enzyme catalyzes the conversion of the substrate analogue to a reactive intermediate, which then irreversibly modifies the enzyme, leading to its inhibition.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CLINICAL IMPORTANCE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Suicide inhibitors have significant implications in drug development, especially for designing drugs that target enzymes involved in disease processes. For instance, certain antibiotics work by suicide inhibition of bacterial enzymes, and some drugs used in the treatment of hypertension and depression also act through this mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understanding the mechanism of suicide inhibition helps in the development of more effective and specific drugs, with fewer off-target effects. It&#39;s a powerful example of how knowledge of biochemistry can be applied in medicinal chemistry and pharmacology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EXAMPLES OF SUICIDE INHIBITORS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta lactams (Penicillins)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allopurinol</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MAO inhibitors</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 28444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56826,
      "choices": [
        {
          "id": 226697,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Measles</span></span></span></p>"
        },
        {
          "id": 226698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Rubella</span></span></span></p>"
        },
        {
          "id": 226699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cat scratch disease</span></span></span></p>"
        },
        {
          "id": 226700,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Langerhans cell histiocytosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 7-year-old boy is brought to the emergency department with high fever, cough, and a widespread rash that started on his face and spread to his body over the past three days. He also has conjunctivitis and runny nose. His parents report that he has not received his vaccinations. On physical examination, he appears ill with generalized lymphadenopathy. A lymph node biopsy is performed, and the histological examination reveals multinucleated giant cells with eosinophilic nuclear and cytoplasmic inclusion bodies. These cells are indicated by arrows in the image. Based on these histological findings, which diagnosis is most likely?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/3.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1947831",
      "question_audio": null,
      "question_video": null,
      "map_id": 12280927,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: A. Measles</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The histological image shows Warthin-Finkeldey giant cells, which are multinucleated giant cells with eosinophilic nuclear and cytoplasmic inclusions, characteristic of measles. These cells are pathognomonic for measles and can be found in lymphoid tissues, the lung, and sputum. They often appear within enlarged germinal centers and are associated with marked follicular hyperplasia. Warthin-Finkeldey cells are specific to measles and are not typically seen in other common viral infections, helping to differentiate measles from other conditions with similar clinical presentations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option B. Rubella</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Rubella can cause lymphadenopathy and a rash similar to measles, but it does not produce Warthin-Finkeldey giant cells. Rubella primarily affects the skin and lymph nodes but lacks the characteristic multinucleated giant cells with inclusions seen in measles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option C. Cat scratch disease</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cat scratch disease, caused by Bartonella henselae, presents with regional lymphadenopathy and suppurative inflammation. The histological hallmark is granulomatous inflammation with stellate necrosis, but it does not feature Warthin-Finkeldey giant cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option D. Langerhans cell histiocytosis</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Langerhans cell histiocytosis is characterized by clonal proliferation of Langerhans cells, and histologically it shows large cells with grooved nuclei and abundant eosinophils. It does not present with the multinucleated Warthin-Finkeldey giant cells seen in measles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warthin-Finkeldey giant cells are pathognomonic for measles, presenting as multinucleated giant cells with eosinophilic inclusions that can be seen in lymph nodes, lung tissue, and sputum. Identifying these cells in histological samples is critical for diagnosing measles, especially in patients with classic clinical features and a history of incomplete vaccination</span></span></p>",
      "correct_choice_id": 226697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6965,
      "choices": [
        {
          "id": 27828,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When used with alcohol, the patients develops nausea, vomiting, flushing, chest discomfort and palpitations </span></span></span></p>"
        },
        {
          "id": 27829,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an anti-craving drug for alcohol </span></span></span></p>"
        },
        {
          "id": 27830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be initiated even in minimally motivated person </span></span></span></p>"
        },
        {
          "id": 27831,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Its action persists maximum up to 2-3 days after stopping the drug</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true about disulfiram?&nbsp;</span></span>(INICET Nov 2020)</p>",
      "unique_key": "Q2119624",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281108,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. When used with alcohol, the patients develops nausea, vomiting, flushing, chest discomfort and palpitations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disulfiram, when used concurrently with alcohol, causes an accumulation of acetaldehyde in the body due to its inhibition of the enzyme acetaldehyde dehydrogenase. This leads to a range of unpleasant symptoms, including nausea, vomiting, flushing, chest discomfort, and palpitations, which are part of the Disulfiram-alcohol reaction. This reaction is intentional and serves as a deterrent to alcohol consumption. It is given at a dose of 250mg/day, dose may be increased up to 500 mg/day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Disulfiram is not primarily an anti-craving drug for alcohol. It works by creating an aversive reaction to alcohol rather than reducing the craving for alcohol. Medications like naltrexone or acamprosate are more accurately described as anti-craving drugs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Disulfiram should be prescribed to highly motivated individuals. It requires a commitment to abstain from alcohol due to the serious nature of the Disulfiram-alcohol reaction. It is not typically recommended for individuals who are minimally motivated or likely to continue consuming alcohol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The action of Disulfiram can persist beyond 2-3 days after stopping the drug. Its inhibitory effect on acetaldehyde dehydrogenase can last for up to a week or more in some cases, making it possible for the Disulfiram-alcohol reaction to occur even several days after the last dose of Disulfiram.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disulfiram, when used concurrently with alcohol, causes a severe and unpleasant reaction due to the accumulation of acetaldehyde, including nausea, vomiting, flushing, chest discomfort, and palpitations, serving as a deterrent to alcohol consumption. It should be used in highly motivated individuals committed to abstaining from alcohol.</span></span></span></p>",
      "correct_choice_id": 27828,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16135,
      "choices": [
        {
          "id": 64500,
          "text": "<p><span style=\"font-size:12pt;\">Lymphedema</span></p>"
        },
        {
          "id": 64501,
          "text": "<p><span style=\"font-size:12pt;\">Arterial Disorders</span></p>"
        },
        {
          "id": 64502,
          "text": "<p><span style=\"font-size:12pt;\">Venous Disorders</span></p>"
        },
        {
          "id": 64503,
          "text": "<p><span style=\"font-size:12.0pt;\">Coronary heart disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 35-year-old male pt presented to your clinic with persistent non-pitting edema in their lower extremities as shown below. What could be the most likely reason for this symptom?&nbsp;(NEET PG 2020)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-153334.jpg\" alt=\"\" width=\"350\" height=\"422\"></p>",
      "unique_key": "Q4623278",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281109,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Lymphedema</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lymphedema is the likeliest cause.</span></li><li><span style=\"font-size:12pt;\">It involves the build-up of protein-rich fluid in tissue interstitial spaces.</span></li><li><span style=\"font-size:12pt;\">It shows typical “non-pitting” edema in the second stage of lymphedema.</span></li><li><span style=\"font-size:12pt;\">Filariasis is the most common etiology.</span></li><li><span style=\"font-size:12pt;\">In severe and long standing cases, skin changes are seen giving the limb an appearance of “Elephantiasis”.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Arterial Disorders:</strong> Arterial disorders may lead to symptoms such as leg pain, intermittent claudication, and tissue damage due to reduced blood supply. Edema is uncommon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Venous Disorders:</strong> These disorders can encompass conditions like deep vein thrombosis (DVT), varicose veins, chronic venous insufficiency (CVI), and venous ulcers. Venous disorders may result in symptoms like leg swelling, pain, and skin changes, and they can vary in severity. No evidence of skin changes associated with varicose veins are seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coronary Heart Disease:</strong> Coronary heart disease (CHD), also known as coronary artery disease (CAD), is a common heart condition where the coronary arteries that supply blood to the heart muscle become narrowed or blocked due to the buildup of fatty deposits (atherosclerosis). CAD may lead to heart failure leading to bilateral lower limb pitting edema, which is not seen in the case above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lymphedema is characterized by non-pitting edema due to the accumulation of protein-rich fluid in the tissue interstitial spaces. It can lead to significant swelling and skin changes, particularly in the lower extremities, distinguishing it from other causes of edema.</span></p>",
      "correct_choice_id": 64500,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56827,
      "choices": [
        {
          "id": 226701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Toxoplasmosis</span></span></span></p>"
        },
        {
          "id": 226702,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Echinococcus multilocularis</span></span></span></p>"
        },
        {
          "id": 226703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Herpes meningitis</span></span></span></p>"
        },
        {
          "id": 226704,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryptococcus</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old HIV-positive patient presented to the emergency department with symptoms of fever, neck pain, and vomiting. He subsequently died, and the brain&#39;s appearance at autopsy, along with the micrograph shown below, suggests a specific pathogen. What is the most likely pathogen&nbsp; involved? (AIIMS NOV 2016)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/4_z1SykWM.jpg\" style=\"height:221px; width:400px\" /></span></span></p>",
      "unique_key": "Q8297143",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281110,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: D. Cryptococcus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The diagnosis is supported by the clinical presentation of meningoencephalitis and the distinctive &quot;soap bubble&quot; lesions observed in the brain parenchyma, a hallmark of Cryptococcus infection in HIV-infected patients. Cryptococcus, a yeast with a thick gelatinous capsule, is known for its CNS involvement, particularly in immunocompromised hosts. This organism can expand perivascular spaces in the gray matter without significant inflammatory response, especially in those with weakened immune systems, such as HIV/AIDS patients. These expansions, termed &quot;soap bubble&quot; lesions, are pathognomonic for cryptococcal infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><strong>Option A. Toxoplasmosis</strong> typically presents with multiple ring-enhancing lesions in the CNS, which differ from the &quot;soap bubble&quot; appearance.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><strong>Option B. Echinococcus multilocularis</strong> causes cystic lesions in organs like the liver and lungs, not typically presenting with &quot;soap bubble&quot; lesions in the brain.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><strong>Option C. Herpes meningitis</strong> is more likely to cause a diffuse meningeal inflammation rather than the distinct lesions seen with Cryptococcus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objectives:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cryptococcus is known for producing &quot;soap bubble&quot; lesions in the CNS, a distinctive feature crucial for diagnosing cryptococcal meningoencephalitis in HIV-positive patients.</span></span></span></p>",
      "correct_choice_id": 226704,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54493,
      "choices": [
        {
          "id": 217441,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deletion</span></span></span></p>"
        },
        {
          "id": 217442,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
        },
        {
          "id": 217443,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amplification</span></span></span></p>"
        },
        {
          "id": 217444,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Translocation</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fluorescent in situ hybridization cannot be useful for detection of which of the following genetic defects?&nbsp;</span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6722765",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281171,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Point mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutation:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutations involve a change in a single nucleotide base pair, which FISH cannot detect because it is designed to detect larger structural changes. For detecting point mutations, more sensitive techniques like polymerase chain reaction (PCR) and specific variants such as single base primer extension assays are used.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes binding parts of the chromosome to detect and localize the presence or absence of specific DNA sequences. It is particularly useful for identifying genetic abnormalities such as deletions, amplifications, and translocations by visualizing the chromosomal location of the gene of interest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Deletion:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> FISH can detect deletions by showing the absence of a fluorescent signal where the probe should bind.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Amplification:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> FISH can detect gene amplifications by showing multiple fluorescent signals in the region of interest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: Translocation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> FISH can detect translocations by showing split signals in different parts of the chromosome or in different chromosomes, indicating that parts of the chromosome have been rearranged.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FISH is not suitable for detecting point mutations but is effective for identifying larger genetic abnormalities such as deletions, amplifications, and translocations.</span></span></span></p>",
      "correct_choice_id": 217442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8778,
      "choices": [
        {
          "id": 35079,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume expired after normal inspiration</span></p>"
        },
        {
          "id": 35080,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume that remains in lungs after forced expiration</span></p>"
        },
        {
          "id": 35081,
          "text": "<p><span style=\"font-size:12.0pt;\">Expiratory reserve volume + residual volume</span></p>"
        },
        {
          "id": 35082,
          "text": "<p><span style=\"font-size:12.0pt;\">Tidal volume + inspiratory reserve volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following represents functional residual capacity?&nbsp;(NEET PG 2019)</span></p>",
      "unique_key": "Q9313989",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281172,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Expiratory reserve volume + residual volume</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The functional residual capacity equals the expiratory reserve volume(1000-1100ml) + residual volume(1100-1200ml). This is the amount of air that remains in the lungs at the end of normal expiration (about 2300 milliliters).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vital capacity</strong> - Total volume of air that can be forcefully expired after forceful inspiration</span></p><p><br><span style=\"font-size:12.0pt;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; = Tidal volume + inspiratory reserve volume + Expiratory reserve volume</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Expiratory capacity</strong> – tidal volume + ERV</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Residual volume&nbsp;</strong>(1100-1200) - Volume that remains after forced expiration</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/672.jpg\" alt=\"\" width=\"707\" height=\"585\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Volume expired after normal inspiration</strong>: Incorrect as this description fits more closely with tidal volume, which is the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Volume that remains in lungs after forced expiration</strong>: Incorrect as this specifically defines residual volume (RV), not the combination of ERV and RV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tidal volume + inspiratory reserve volume</strong>: Incorrect, this combination describes the inspiratory capacity, which is the total volume of air that can be exhaled after a maximal inhalation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Functional Residual Capacity (FRC) is the sum of the Expiratory Reserve Volume (ERV) and the Residual Volume (RV). It represents the volume of air remaining in the lungs at the end of a normal exhalation, ensuring continuous gas exchange between breaths.</span></p>",
      "correct_choice_id": 35081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14000,
      "choices": [
        {
          "id": 55961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">27%</span></span></span></span></p>"
        },
        {
          "id": 55962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36%</span></span></span></span></p>"
        },
        {
          "id": 55963,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45%</span></span></span></span></p>"
        },
        {
          "id": 55964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">18%</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old woman presented with burns injury. She is covered with burns on her head and neck, both upper limbs, front and back of the chest. Calculate the percentage of burns? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q6042555",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281173,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 45%</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To calculate the percentage of burns, the &quot;<strong>Rule of Nines</strong>&quot; is commonly used in medicine. According to this rule, each area of the body is assigned a percentage value. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For example, the <strong>head and neck</strong> are typically assigned <strong>9%,</strong> each <strong>upper limb is assigned 9% (18%</strong> <strong>total for both),</strong> and the <strong>front and back</strong> of the <strong>chest are assigned 18%.</strong> When we <strong>add these percentages together,</strong> we get a <strong>total of 45% burns.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The percentage of burns calculated in the given patient is 45% according to Wallace&#39;s rule of nine.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on the head &amp; neck would account for 9% of burns.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on both upper limbs (9% for each limb) would add to 18%</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on both sides of the chest would account for 18%</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the total percentage of burns in the given patient is 9+18+18 = 45%</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wallace&#39;s rule of nine:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-90_poZazyg.jpg\" style=\"height:529px; width:484px\" /></span></strong></span></span></p>",
      "correct_choice_id": 55963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23204,
      "choices": [
        {
          "id": 92780,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 92781,
          "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-A, 3-B, 4-D</span></p>"
        },
        {
          "id": 92782,
          "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 92783,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following :&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/04/screenshot-2023-11-04-192316.png\" alt=\"\" width=\"700\" height=\"274\"></span></p>",
      "unique_key": "Q2188219",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281174,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 1-B, 2-A, 3-C, 4-D</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Facial nerve - B. Taste from anterior two-thirds of the tongue</strong>: The facial nerve (CN VII) is responsible for carrying taste sensations from the anterior two-thirds of the tongue. It also controls the muscles of facial expression.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Spinal accessory nerve - A. Shrugging of the shoulder:</strong> The spinal accessory nerve (CN XI) innervates the trapezius muscle, which is responsible for actions such as shrugging the shoulder and scapula elevation. It also contributes to head rotation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glossopharyngeal nerve - C. Taste from the posterior one-third of the tongue</strong>: The glossopharyngeal nerve (CN IX) carries taste sensations from the posterior one-third of the tongue. It also plays a role in swallowing and provides sensory information from the throat and tonsils.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mandibular nerve - D. Chewing:</strong> The mandibular nerve (V3) is a branch of the trigeminal nerve (CN V) and is responsible for innervating the muscles of mastication (chewing), as well as providing sensory input to the lower jaw, teeth, and gums.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-125921.JPG\" alt=\"\" width=\"700\" height=\"229\"></strong></span></p>",
      "correct_choice_id": 92783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10365,
      "choices": [
        {
          "id": 41426,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myxoid liposarcoma</span></span></span></p>"
        },
        {
          "id": 41427,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lipoma</span></span></span></p>"
        },
        {
          "id": 41428,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spindle lipoma</span></span></span></p>"
        },
        {
          "id": 41429,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polymorphic lipoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presented with a retroperitoneal mass. Biopsy from the lesion is shown in the image below. Molecular analysis revealed t(12;16). What is the most likely condition? (NEET PG 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-398.jpg\" style=\"height:261px; width:400px\" /></p>",
      "unique_key": "Q3813138",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281175,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Myxoid liposarcoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario is suggestive of <strong>myxoid liposarcoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows a <strong>lot of ground substance, as well as some branching capillaries and immature adipocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liposarcoma is the most common sarcoma in adults, typically appearing in <strong>the fifth to sixth decade of life.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are most commonly found in the <strong>proximal extremities (deep soft tissues</strong>) and the retroperitoneum.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically the liposarcomas are divided into four subtypes:&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Well-differentiated liposarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: resembles lipoma but contains uni- or multi-vacuolated lipoblasts. It is associated with <strong>amplification of 12q13-g15.</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myxoid liposarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Most common histologic type. It is composed of monomorphic, fusiform or stellate cells representing primitive mesenchymal cells, lying dispersed in mucopolysaccharide-rich ground substance. Occasional tumor giant cells may be present. Prominent meshwork of capillaries forming chicken-wire patterns is a conspicuous feature. It is associated with <strong>t (12;16).</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Round cell liposarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is composed of uniform, round to oval cells having fine multi vacuolated cytoplasm with central hyperchromatic nuclei. Round cell liposarcoma may resemble a <strong><em>signet-ring carcinoma</em></strong> but mucin stains help in distinguishing the two.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pleomorphic liposarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> highly undifferentiated and the most anaplastic type. There are numerous large tumor giant cells and bizarre lipoblasts.&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Lipomas are benign tumors of adipose tissue and do not show the histological features or molecular translocation (t (12;16)) seen in myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Spindle lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Spindle cell lipomas are benign tumors composed of spindle-shaped cells mixed with mature adipocytes and do not have the mucopolysaccharide-rich ground substance or the t (12;16) translocation seen in myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Polymorphic lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Polymorphic lipomas are also benign and do not exhibit the characteristic histological features or molecular markers of myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myxoid liposarcoma is the most common histologic type of liposarcoma, characterized by a mucopolysaccharide-rich ground substance, a prominent capillary network forming chicken-wire patterns, and the presence of the translocation t (12;16).</span></span></span></p>",
      "correct_choice_id": 41426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7061,
      "choices": [
        {
          "id": 28212,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Labile hypertension</span></span></span></p>"
        },
        {
          "id": 28213,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary hypertension</span></span></span></p>"
        },
        {
          "id": 28214,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of resistant migraine</span></span></span></p>"
        },
        {
          "id": 28215,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistant Parkinson&#39;s disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhaled Nitric oxide is approved for treatment of? (</span></span>INICET May 2021)</p>",
      "unique_key": "Q6194604",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281176,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pulmonary hypertension</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide (NO) has specific clinical applications, particularly in the field of pulmonary medicine. It is approved for the treatment of pulmonary hypertension, especially in certain acute settings. It works by selectively dilating the pulmonary vessels by increasing cyclic guanosine monophosphate (cGMP), thereby reducing pulmonary artery pressure and improving oxygenation. Inhaled nitric oxide is particularly noted for its use in newborns with hypoxic respiratory failure associated with pulmonary hypertension. It can also be used in the acute management of pulmonary hypertension in adults during cardiac surgery or critical care settings.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Labile Hypertension</strong>: Inhaled nitric oxide is not used for the treatment of labile hypertension. Hypertension is typically managed with systemic medications rather than inhaled agents.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of Resistant Migraine</strong>: Inhaled nitric oxide is not a standard treatment for migraines, whether typical or resistant. Migraine treatment usually involves a range of other pharmacological interventions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Resistant Parkinson&#39;s Disease</span></strong><span style=\"font-size:12.0pt\">: There is no established role for inhaled nitric oxide in the treatment of Parkinson&rsquo;s disease. Parkinson&#39;s disease management primarily involves medications that affect dopamine pathways.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other uses of inhaled Nitric Oxide:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neonatal Care</span></strong><span style=\"font-size:12.0pt\">: It is particularly valuable in the treatment of newborns with persistent pulmonary hypertension of the newborn (PPHN) to improve oxygenation.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS)</span></strong><span style=\"font-size:12.0pt\">: While its benefits in ARDS in adults are still a subject of research and debate, it has been used for its pulmonary vasodilator effects in some critical care settings.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cardiac Surgery</span></strong><span style=\"font-size:12.0pt\">: Inhaled NO can be used during cardiac surgery to control pulmonary artery pressures.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lung Transplantation</span></strong><span style=\"font-size:12.0pt\">: It may be used to reduce pulmonary hypertension and improve graft function immediately after transplantation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide is approved for the treatment of pulmonary hypertension, particularly in acute settings to reduce pulmonary artery pressure and improve oxygenation. It is not used for labile hypertension, migraines, or Parkinson&#39;s disease.</span></span></span></p>",
      "correct_choice_id": 28213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11697,
      "choices": [
        {
          "id": 46754,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PSVT </span></span></span></span></p>"
        },
        {
          "id": 46755,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy</span></span></span></span></p>"
        },
        {
          "id": 46756,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P pulmonale</span></span></span></span></p>"
        },
        {
          "id": 46757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Re-entrant atrial fibrillation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given ECG depicts which of the following conditions:&nbsp; (AIIMS NOV 2018)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm112.jpg\" style=\"height:357px; width:700px\" /></p>",
      "unique_key": "Q5885480",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281177,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ventricular bigeminy </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ventricular complex (PVCs)- Have following features </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Broad QRS complex (&gt;120ms) with abnormal morphology</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature- i.e., occurs earlier than would be expected for the next sinus impulse</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discordant ST segment and T wave changes.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usually followed by a full compensatory pause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PVCs often occur in repeating pattern: bigeminy, trigeminy, quadrigeminy </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Couplet: 2 consecutive PVCs is known as couplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triplet: 3 consecutive PVCs is known as triplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. PSVT (Paroxysmal Supraventricular Tachycardia):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition would show a fast, regular heart rate with narrow QRS complexes; not observed here.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. P pulmonale:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This involves peaked P waves seen in leads II, III, and aVF, typically due to right atrial enlargement; not evident in this ECG.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Re-entrant atrial fibrillation:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Would show an irregularly irregular rhythm without consistent P waves; this is not present in the ECG provided.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy is identified by the presence of alternating normal sinus beats and PVCs, each PVC typically followed by a compensatory pause, creating a repeating pattern of one normal beat followed by one abnormal beat.</span></span></span></span></p>",
      "correct_choice_id": 46755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10490,
      "choices": [
        {
          "id": 41926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff body; Rheumatic heart disease</span></span></span></p>"
        },
        {
          "id": 41927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcification of valve; Mitral stenosis</span></span></span></p>"
        },
        {
          "id": 41928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granuloma; Sarcoidosis</span></span></span></p>"
        },
        {
          "id": 41929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-caseating granuloma; Tuberculosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with complaints of dyspnea on exertion for 1 month. Echocardiography showed the presence of mitral stenosis and left ventricular hypertrophy. Identify the histopathological finding given below and the probable diagnosis? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-392.jpg\" style=\"height:200px; width:300px\" /></span></span></p>",
      "unique_key": "Q7505772",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281178,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Aschoff body; Rheumatic heart disease</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion shown in the histopathological slide is Aschoff&#39;s body and the most probable diagnosis is rheumatic heart disease (RHD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Aschoff&#39;s bodies have the following components:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anitschkow cells or plump macrophages</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abundant cytoplasm</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caterpillar cells - refer to centrally condensed chromatin into slender, wavy ribbons</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foci of fibrinoid necrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff&#39;s giant cells - multinucleated larger macrophages</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">T-cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Plasma cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcification of valve; Mitral stenosis</span></strong><span style=\"font-size:12.0pt\">: While mitral stenosis can result from calcification, it is more typically associated with chronic rheumatic heart disease, which involves Aschoff bodies rather than calcification alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Granuloma; Sarcoidosis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis is characterized by non-caseating granulomas, but it does not present with Aschoff bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Non-caseating granuloma</span></strong><span style=\"font-size:12.0pt\">:<strong> Tuberculosis:</strong> Tuberculosis typically presents with caseating granulomas, not Aschoff bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aschoff bodies&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are indicative of <strong>Rheumatic heart disease (RHD)</strong>, and their presence supports the diagnosis in a patient with clinical features such as mitral stenosis and left ventricular hypertrophy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1044</span></strong></span></span></p>",
      "correct_choice_id": 41926,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56828,
      "choices": [
        {
          "id": 226705,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate cancer</span></p>"
        },
        {
          "id": 226706,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cell lung cancer</span></p>"
        },
        {
          "id": 226707,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoid tumor</span></p>"
        },
        {
          "id": 226708,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man presents to his primary care physician with complaints of persistent lower back pain and difficulty walking, which have progressively worsened over the last six months. He has no history of recent trauma or significant injury. On examination, he has tenderness over the lumbar spine and limited range of motion due to pain. Laboratory tests show elevated alkaline phosphatase levels. A bone scan reveals multiple areas of increased uptake in the spine and pelvis, and X-rays show dense, sclerotic lesions in these areas. Based on these imaging findings, which condition is most commonly associated with predominantly osteoblastic metastases?</span></p>",
      "unique_key": "Q5391213",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281279,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Correct Answer: A. Prostate cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Breakdown of the Case:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Elderly male (70 years old)</span></li><li><span style=\"font-size:16px;\">Persistent lower back pain and difficulty walking – suggests spinal pathology</span></li><li><span style=\"font-size:16px;\">No trauma – rules out mechanical cause</span></li><li><span style=\"font-size:16px;\">Localized spinal tenderness and reduced mobility – possible vertebral pathology</span></li><li><span style=\"font-size:16px;\">Elevated ALP – marker of increased bone turnover (often seen in bone metastases)</span></li><li><span style=\"font-size:16px;\">Bone scan – shows increased uptake in spine and pelvis (common sites for prostate mets)</span></li><li><span style=\"font-size:16px;\">X-rays show dense, sclerotic lesions – hallmark of osteoblastic metastases</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Predominantly osteoblastic metastases, characterized by sclerotic or dense bone lesions, are most commonly seen in prostate cancer. Prostate cancer is known for metastasizing to the bone, where it induces osteoblastic activity, leading to increased bone formation and sclerotic changes visible on imaging. While other cancers such as small cell lung cancer, carcinoid tumors, and Hodgkin lymphoma can also cause osteoblastic metastases, prostate cancer is the classic and most frequently associated malignancy with this pattern of bone involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Small cell lung cancer: </strong>Small cell lung cancer can occasionally produce osteoblastic metastases, but it is much less common compared to prostate cancer. Osteoblastic lesions in small cell lung cancer are relatively rare and usually mixed with osteolytic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Carcinoid tumor: </strong>Carcinoid tumors can cause osteoblastic metastases, but these are relatively uncommon. They usually present with other systemic symptoms related to hormone production rather than extensive sclerotic bone lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Hodgkin lymphoma: </strong>Hodgkin lymphoma can cause sclerotic bone metastases, particularly in advanced stages. However, this is less common compared to the classic osteoblastic metastases seen in prostate cancer, making Hodgkin lymphoma a less likely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Osteoblastic metastases, which appear as dense, sclerotic lesions on imaging, are most commonly associated with prostate cancer due to its propensity to promote new bone formation at metastatic sites.&nbsp;</span></p>",
      "correct_choice_id": 226705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10092,
      "choices": [
        {
          "id": 40334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-d, 2- c, 3- b, 4-a</span></span></span></p>"
        },
        {
          "id": 40335,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2- a, 3- d, 4- b</span></span></span></p>"
        },
        {
          "id": 40336,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-a, 2-b, 3- d, 4-c</span></span></span></p>"
        },
        {
          "id": 40337,
          "text": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-b, 2-a, 3-c, 4-d</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following stains with their respective tissue:</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-160905.jpg\" style=\"height:298px; width:700px\" /></p>",
      "unique_key": "Q2233717",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281350,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 1-a, 2-b, 3-d, 4-c</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct match is 1- a, 2- b, 3- d, 4-c.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prussian blue (a)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to detect <strong>iron</strong> in tissue samples, specifically hemosiderin, a storage form of iron.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PAS (b)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The <strong>Periodic Acid-Schiff (PAS)</strong> stain is used to highlight <strong>glycogen</strong> and other carbohydrates in tissues. It is commonly used in diagnosing certain storage diseases and fungal infections.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congo red (c)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Congo red is a special stain used to detect <strong>amyloid</strong>, a protein that can abnormally accumulate in tissues, leading to conditions such as amyloidosis. Under polarized light, amyloid stained with Congo red shows apple-green birefringence.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fite Faraco stain (d)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to detect <strong>leprosy</strong> bacilli (Mycobacterium leprae) in tissue samples. It is a modification of the acid-fast stain and is specifically tailored to highlight these bacteria.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161158.jpg\" style=\"height:1112px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161508.jpg\" style=\"height:887px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161538.jpg\" style=\"height:804px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 40336,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10010,
      "choices": [
        {
          "id": 40006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 40007,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
        },
        {
          "id": 40008,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Large cell carcinoma</span></span></span></p>"
        },
        {
          "id": 40009,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male, with a smoking history of 20 pack years, presented in OPD with breathlessness and chest pain. Further investigations revealed a lung tumor. On staining, cells are positive for chromogranin. What is the likely diagnosis? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9873234",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281351,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Small cell carcinoma&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of chronic smoking and lung tumor cells staining positive for chromogranin suggests small cell carcinoma of the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SMALL CELL CARCINOMAS:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This highly malignant tumor has a distinctive cell type. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strongly associated with cigarette smoking</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This lung cancer type is most commonly associated with ectopic hormone production</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Electron microscopy shows </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dense-core neurosecretory granules are present along the bronchial epithelium which can secrete polypeptide hormones</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of neuroendocrine markers such as chromogranin, synaptophysin, and CD57 (in 75% of cases) and parathormone-like and other hormonally active products suggest derivation of this tumor from neuroendocrine progenitor cells of the lining bronchial epithelium. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Adenocarcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is the most common subtype of lung cancer, especially in non-smokers, and it typically involves peripheral lung lesions. It is characterized by markers like TTF-1, NAPSIN-A, and CEA, rather than chromogranin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Squamous cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type is also associated with smoking but is more likely to present centrally in the lungs. It shows keratinization and intercellular bridges on histology and is associated with markers like p40 and p63, not chromogranin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Large cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This diagnosis is typically a diagnosis of exclusion and does not have a specific marker like chromogranin. It is also more common in non-smokers and presents as a peripheral tumor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311.jpg\" style=\"height:733px; width:800px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-144842.jpg\" style=\"height:658px; width:1000px\" /></span></span></span></span></p>",
      "correct_choice_id": 40009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10319,
      "choices": [
        {
          "id": 41242,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herpes-simplex virus</span></span></span></p>"
        },
        {
          "id": 41243,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cytomegalovirus</span></span></span></p>"
        },
        {
          "id": 41244,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida</span></span></span></p>"
        },
        {
          "id": 41245,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Punched-out ulcers in the esophagus are caused by: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q1014123",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281352,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Herpes-simplex virus </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infection with the Herpes simplex virus (HS) causes <strong>punched-out ulcers in the esophagus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunocompromised patients are more likely to develop HS esophagitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endoscopic findings may include multiple discrete or coalescent small ulcers that appear superficial, punched out, or volcano-like.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/5_aYMBZut.jpg\" style=\"height:234px; width:329px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For diagnosis, the biopsy sample should be taken from the edge of the ulcer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The following microscopic findings are seen here:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ballooning degeneration</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ground-glass changes in nuclei</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infected squamous epithelial cells show<strong> 3 M&rsquo;</strong>s:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">olding of nuclear contours</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">argination of chromatin to the periphery of nuclei</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ultinucleation </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intranuclear inclusions:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cowdry type A:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> acidophilic inclusion with surrounding clear halo </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Equivocal cases require an HSV immunohistochemical (IHC) stain to confirm the diagnosis</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-124341.png\" style=\"height:223px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cytomegalovirus (CMV)</span></strong><span style=\"font-size:12.0pt\">: Causes larger, shallow ulcers and might involve deeper tissue layers, with &quot;owl&#39;s eye&quot; inclusions typically seen.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Candida</span></strong><span style=\"font-size:12.0pt\">: Presents typically as white plaques or linear fissures rather than punched-out ulcers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acid</span></strong><span style=\"font-size:12.0pt\">: Causes erosive esophagitis with continuous areas of inflammation rather than discrete ulcers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Herpes simplex virus causes distinctive punched-out ulcers in the esophagus, particularly noted in immunocompromised patients, diagnosed by endoscopic appearance and confirmed via histopathological findings.</span></span></span></p>",
      "correct_choice_id": 41242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10066,
      "choices": [
        {
          "id": 40230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gonadal mosaicism</span></span></span></p>"
        },
        {
          "id": 40231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genomic imprinting</span></span></span></p>"
        },
        {
          "id": 40232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anticipation</span></span></span></p>"
        },
        {
          "id": 40233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete penetrance</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the phenomenon of a differential effect of the same gene from different parents?</span> <span style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q9100550",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281353,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Genomic imprinting</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic Imprinting is the phenomenon of a differential effect of the same gene from different parents.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important functional differences exist between the paternal allele and the maternal allele. These differences result from an epigenetic process, called imprinting. In most cases, imprinting selectively inactivates either the maternal or paternal allele. Thus, maternal imprinting refers to transcriptional silencing of the maternal allele, whereas paternal imprinting implies that the paternal allele is inactivated. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic imprinting is&nbsp;a process of silencing genes through DNA methylation. The repressed allele is methylated, while the active allele is unmethylated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Prader-Willi syndrome and Angelman syndrome. Both of these syndromes can be caused by imprinting or other errors involving genes on the long arm of chromosome 15.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Gonadal mosaicism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Gonadal mosaicism refers to the presence of more than one genetically distinct cell line within the gonads. This can lead to different genetic outcomes in offspring but does not involve the differential effect of the same gene based on parental origin. Therefore, it is not related to genomic imprinting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Anticipation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anticipation is a phenomenon where a genetic disorder appears earlier and with increased severity in successive generations. This is different from genomic imprinting, as it does not involve the differential effects of a gene based on whether it is inherited from the mother or the father.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Incomplete penetrance</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Incomplete penetrance occurs when not all individuals carrying a disease-causing mutation exhibit the disease phenotype. This concept is unrelated to the differential effect of a gene based on its parental origin and does not describe genomic imprinting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic imprinting is an epigenetic process where the same gene can have different effects depending on whether it is inherited from the mother or the father, typically through mechanisms like DNA methylation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 328</span></strong></span></span></p>",
      "correct_choice_id": 40231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9844,
      "choices": [
        {
          "id": 39342,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">They can differentiate</span></span></span></p>"
        },
        {
          "id": 39343,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">They can replicate</span></span></span></p>"
        },
        {
          "id": 39344,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">They can divide without any regulatory stimulus</span></span></span></p>"
        },
        {
          "id": 39345,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">They can regenerate damaged tissues</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Which of the following is not true about stem cells? (AIIMS MAY 2020)</span></span></span></p>",
      "unique_key": "Q5995666",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281354,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) They can divide without any regulatory stimulus</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Stem cells do not divide without any regulatory stimulus.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Stem cells are characterized by their self-renewal properties and by their capacity to generate differentiated cell lineages. Stem cells give rise to all the various differentiated tissues. In adults, stem cells replace damaged cells and maintain tissue populations.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The properties of stem cells are:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Obligatory asymmetric replication</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">, in which with each stem cell division, one of the daughter cells retains its self-renewing capacity while the other enters a differentiation pathway</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Stochastic differentiation</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">, in which a stem cell population is maintained by the balance between stem cell divisions that generate either two self-renewing stem cells or two cells that will differentiate.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The types of stem cells are:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Embryonic stem cells which are totipotent</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Adult stem cells present in stem cell niches</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The pluripotency of stem cells is due to factors like:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Oct3/4</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Kif 4</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Sox 2</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">c-myc</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. They can differentiate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is true. Stem cells have the ability to differentiate into various specialized cell types.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. They can replicate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is true. Stem cells can self-renew, meaning they can replicate themselves to maintain the stem cell pool.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. They can regenerate damaged tissues</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is true. Stem cells can help regenerate damaged tissues by differentiating into the necessary cell types to replace lost or damaged cells.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stem cells do not divide without any regulatory stimulus; their division and differentiation are tightly controlled to maintain tissue homeostasis and prevent uncontrolled growth.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:</span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> Robbins and Cotran Pathologic basis of disease 8<sup>th</sup> edition pg 165-170</span></strong></span></span></p>",
      "correct_choice_id": 39344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9926,
      "choices": [
        {
          "id": 39670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></span></span></span></p>"
        },
        {
          "id": 39671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></span></span></p>"
        },
        {
          "id": 39672,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></span></span></p>"
        },
        {
          "id": 39673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following structure is affected in pancreas of a patient with Cystic Fibrosis?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/10.jpg\" style=\"height:190px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q5299901",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The part labelled &#39;B&#39; in the image is the acini (exocrine pancreas) which is affected in cystic fibrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/11.jpg\" style=\"height:320px; width:446px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In Cystic Fibrosis, there is accumulation mucin in ducts of pancreas which leads to atrophy of exocrine pancreas. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-173452.jpg\" style=\"height:983px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Likely corresponds to a blood vessel, which is not primarily affected in CF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Corresponds to a larger duct, which may also be obstructed by mucus, but the question specifically asks about the structure most commonly affected, which is the acini.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: May correspond to an islet of Langerhans (endocrine pancreas), which is less commonly affected in the early stages of CF compared to the exocrine acini.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In Cystic Fibrosis, the acini (exocrine pancreas) are primarily affected due to mucus accumulation in the ducts, leading to atrophy and fibrosis of the exocrine pancreas.</span></span></span></p>",
      "correct_choice_id": 39671,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9775,
      "choices": [
        {
          "id": 39067,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
        },
        {
          "id": 39068,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
        },
        {
          "id": 39069,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic cirrhosis</span></span></span></p>"
        },
        {
          "id": 39070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nephrotic syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the most likely diagnosis based on the given serum electrophoresis image (pink)?</span> </span></span>(AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/927.jpg\" style=\"height:309px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q5263339",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Nephrotic syndrome</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given electrophoresis picture shows hypoalbuminemia and increased alpha-2 globulin, which is suggestive of nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/928.jpg\" style=\"height:287px; width:677px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/929.jpg\" style=\"height:564px; width:724px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Multiple myeloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Multiple myeloma would typically present with a sharp, monoclonal spike in the gamma region (known as an M-spike or paraprotein spike) due to the overproduction of a single type of immunoglobulin by malignant plasma cells. This pattern is not seen in the provided electrophoresis image.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Tuberculosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Tuberculosis is generally associated with a chronic inflammatory response and can show a polyclonal increase in the gamma region due to chronic immune activation. However, it does not show the specific hypoalbuminemia and alpha-2 globulin increase seen in nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hepatic cirrhosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In hepatic cirrhosis, the electrophoresis pattern often shows a polyclonal increase in the gamma region (polyclonal gammopathy), sometimes with a beta-gamma bridging pattern. This pattern is not consistent with the hypoalbuminemia and alpha-2 globulin increase observed in nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The electrophoresis pattern showing hypoalbuminemia combined with an increase in alpha-2 globulin is most indicative of nephrotic syndrome, reflecting the characteristic loss of albumin and retention of larger plasma proteins in this condition.</span></span></span></p>",
      "correct_choice_id": 39070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10005,
      "choices": [
        {
          "id": 39986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IFN gamma (Interferon-gamma)</span></span></span></p>"
        },
        {
          "id": 39987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 2 (Interleukin-2)</span></span></span></p>"
        },
        {
          "id": 39988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 12 (Interleukin-12)</span></span></span></p>"
        },
        {
          "id": 39989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following cytokines is not involved in Th1 response?&nbsp;(INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q3807786",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) IL- 4</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The cytokine not involved in TH1 response is IL-4.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T-cell response in this early stage is dominated by TH1 cells that produce IFN-&gamma;, which stimulates macrophages to secrete high levels of the cytokines TNF, IL-1, and IL-6 that cause fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-12 is secreted by macrophages and promotes the proliferation of TH1 cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The 1 cells secrete IL-2 which activates natural killer cells (NK cells) and cytotoxic T cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/3_GQmj9YH.jpg\" style=\"height:242px; width:577px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. IFN-&gamma; (Interferon-gamma)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IFN-&gamma; (Interferon-gamma) is a key cytokine produced by Th1 cells. It activates macrophages and enhances their ability to destroy ingested microbes, and it also promotes the production of IgG antibodies that are essential for opsonization and phagocytosis of pathogens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. IL-2 (Interleukin-2)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IL-2 (Interleukin-2) is produced by Th1 cells and plays a critical role in the activation and proliferation of T cells, including natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), which are crucial for the immune response against intracellular pathogens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. IL-12 (Interleukin-12)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IL-12 (Interleukin-12) is produced by antigen-presenting cells (like dendritic cells and macrophages) and is essential for the differentiation of naive T cells into Th1 cells. It also stimulates the production of IFN-&gamma; by these Th1 cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-114325.jpg\" style=\"height:562px; width:1000px\" /></p>",
      "correct_choice_id": 39989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5813,
      "choices": [
        {
          "id": 23222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Twin to Twin Transfusion Syndrome</span></span></span></p>"
        },
        {
          "id": 23223,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Monochorionic diamniotic pregnancy</span></span></span></p>"
        },
        {
          "id": 23224,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Monochorionic monoamniotic pregnancy</span></span></span></p>"
        },
        {
          "id": 23225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Dichorionic diamniotic pregnancy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify this condition?&nbsp;</span></span>(INICET NOV 2018)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_QSiuVik.jpg\" style=\"height:233px; width:250px\" /></span></span></span></p>",
      "unique_key": "Q5800499",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281358,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Monochorionic monoamniotic pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a monochorionic monoamniotic placenta, characterized by a single placenta with two umbilical cords and no intervening membrane. Monochorionic monoamniotic twins share both a chorion and an amniotic sac. This type of twinning occurs when the inner cell mass divides between days 8 to 12 of gestation, after the formation of the trophoblast, leading to a monochorionic condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic monoamniotic twin gestations have a high fetal death rate due to several complications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preterm birth</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital anomalies</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low birth weight</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cord entanglement</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best time for delivery of monochorionic monoamniotic twins is between 32-34 weeks via Caesarean section.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Twin to Twin Transfusion Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a complication seen in monochorionic twin pregnancies. It involves a donor twin and a recipient twin. The donor twin is anemic, growth-restricted, and has oligohydramnios, while the recipient twin is polycythemic, has polyhydramnios, and suffers from circulatory overload.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Monochorionic diamniotic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In this type of pregnancy, there are two amniotic cavities and one chorion. This occurs when the inner cell mass divides between 4-7 days of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Dichorionic diamniotic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This pregnancy type involves two amniotic cavities and two chorions. It occurs when the inner cell mass divides between 0-3 days of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic monoamniotic pregnancies involve a single placenta with two umbilical cords and no intervening membrane, occurring when the inner cell mass divides between days 8 to 12 of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of Obstetrics 8th edition pg 233-234, </span></strong></span></span></p>",
      "correct_choice_id": 23224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43947,
      "choices": [
        {
          "id": 175451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interferon gamma</span></span></span></p>"
        },
        {
          "id": 175452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complement 5a protein</span></span></span></p>"
        },
        {
          "id": 175453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histamine</span></span></span></p>"
        },
        {
          "id": 175454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fever, cough, weight loss, histology of the pathology is as shown below. What is the most likely cytokine involved? (INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151657.JPG\" style=\"height:256px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2741770",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281359,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Interferon gamma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IFN-</span><span dir=\"ltr\" lang=\"EL\" style=\"font-size:12.0pt\">&gamma; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is crucial in the immune response against intracellular pathogens, including the activation of macrophages and the formation of granulomas, as seen in tuberculosis and other granulomatous diseases. It is produced primarily by T-helper cells (Th1) and is critical for orchestrating the cellular immune response that results in the granuloma formation evident in the provided histology.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Complement 5a protein</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory process, enhancing the immune response by attracting immune cells to sites of infection, but not directly involved in granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Histamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A mediator in allergic reactions, involved in vasodilation and increased vascular permeability, not typically associated with chronic inflammatory or granulomatous responses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Prostaglandin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are lipid compounds that mediate inflammation. Like histamine, they are more often associated with immediate inflammatory responses and pain, rather than chronic inflammation or granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interferon gamma is key in managing intracellular infections and is responsible for the activation of macrophages and other immune cells that culminate in granuloma formation, a central feature in controlling persistent pathogens such as those seen in tuberculosis.</span></span></span></p>",
      "correct_choice_id": 175451,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5714,
      "choices": [
        {
          "id": 22828,
          "text": "<p><span style=\"font-size:12.0pt;\">Laceration</span></p>"
        },
        {
          "id": 22829,
          "text": "<p><span style=\"font-size:12.0pt;\">Incised wound</span></p>"
        },
        {
          "id": 22830,
          "text": "<p><span style=\"font-size:12.0pt;\">Lacerated looking incised wound</span></p>"
        },
        {
          "id": 22831,
          "text": "<p><span style=\"font-size:12.0pt;\">Incised looking lacerated wound</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of injury from the picture given below: (NEET PG 2021)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_k8Mg0qq.jpg\" alt=\"\" width=\"300\" height=\"188\"></span></p>",
      "unique_key": "Q4130302",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281380,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Incised looking lacerated wound</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a lacerated wound which looks like incised wound. This is also called <strong>“Incised looking lacerated wound”</strong>. They occur at bony sites where there is thin subcutaneous tissue like Scalp, forehead, Zygoma, Iliac crest, Shin etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>They can be differentiated from incised wounds by following:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Due to blunt force, there is usually associated abrasions and contusions in the margins</span></li><li><span style=\"font-size:12.0pt;\">Depth of the wound presents bridges of irregularly torn tissue, blood vessels and nerves, etc.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Laceration:</strong> Irregular tear-like wounds caused by blunt trauma. They often have jagged edges and may have tissue bridges at the base. The wound in the image appears cleaner and more linear, resembling an incised wound, making it an incised looking lacerated wound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Incised wound:</strong> Clean, straight cuts typically caused by sharp instruments such as knives or glass. The wound in the image is caused by blunt force and has characteristics of a laceration, despite its appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Lacerated looking incised wound:</strong>&nbsp; In areas where skin folds are loose, like in<strong> axilla, scrotum etc</strong>, the shapes are zigzag type. So, although it is produced by sharp weapon but it looks like lacerated wound. Such wounds are sometimes called as lacerated looking incised wound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An incised looking lacerated wound is caused by blunt force trauma but appears similar to an incised wound due to its location and the characteristics of the tissue involved.</span></p>",
      "correct_choice_id": 22831,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6914,
      "choices": [
        {
          "id": 27624,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of lithium therapy</span></span></span></p>"
        },
        {
          "id": 27625,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of carbamazepine therapy</span></span></span></p>"
        },
        {
          "id": 27626,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of long acting depot antipsychotics</span></span></span></p>"
        },
        {
          "id": 27627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of nicotine patches</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Z track technique is used for (</span></span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q8270281",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281381,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. C. Administration of long acting depot antipsychotics</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Z track technique is a technique used for intramuscular injection.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">During Z track technique, skin is stretched to one side before injecting the needle so that the point of injection and point of deposition of drug are not in straight line. This decreases the risk of efflux back of drug.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Advantages of Z track technique &ndash;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It will not cause any pigmentation</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Lithium and carbamazepine are oral drugs and monitoring is done by taking blood through intravenous route.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Long acting depot antipsychotics are given by intramuscular route via z-track technique.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nicotine patches are applied on the skin.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Monitoring of lithium therapy:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium therapy is monitored through blood tests, not intramuscular injections. Blood samples are taken intravenously to measure lithium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Monitoring of carbamazepine therapy:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine therapy is also monitored through blood tests. Blood samples are taken intravenously to measure carbamazepine levels, and the medication is usually taken orally.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Administration of nicotine patches:&nbsp;</span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotine patches are applied transdermally to the skin. The Z track technique is not relevant for this method of administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Z track technique is used for intramuscular injections, particularly for long-acting depot antipsychotics, to ensure proper deposition of the medication and prevent leakage back through the injection path.</span></span></span></p>",
      "correct_choice_id": 27626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10086,
      "choices": [
        {
          "id": 40310,
          "text": "<p><span style=\"font-size:12.0pt;\">Give continuous prophylaxis to the patient</span></p>"
        },
        {
          "id": 40311,
          "text": "<p><span style=\"font-size:12.0pt;\">Give prophylactic antivirals to the husband</span></p>"
        },
        {
          "id": 40312,
          "text": "<p><span style=\"font-size:12.0pt;\">Give antivirals whenever active lesions are present</span></p>"
        },
        {
          "id": 40313,
          "text": "<p><span style=\"font-size:12.0pt;\">Don't involve in intercourse when active lesions are present</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents with active genital warts with a history of recurrence, but her husband doesn't have it. What advice will you give to prevent transmission? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q3811337",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281382,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Don't involve in intercourse when active lesions are present</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is the correct answer. <strong>Avoiding sexual contact</strong> when active lesions are present is one of the <strong>most effective</strong> ways to <strong>prevent</strong> the <strong>transmission</strong> of HPV.</span></li><li><span style=\"font-size:12.0pt;\">Genital warts are primarily caused by specific types of human papillomavirus <strong>(HPV-6 and HPV-11)</strong>.</span></li><li><span style=\"font-size:12.0pt;\">These warts, also known as <strong>venereal warts or condyloma acuminata</strong>, are highly <strong>infectious</strong> and are commonly acquired through <strong>sexual contact.</strong></span></li><li><span style=\"font-size:12.0pt;\">However, they can <strong>also be transmitted</strong> through <strong>non-sexual</strong> means.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Genital warts&nbsp;</strong>are highly contagious when lesions are active, <strong>so abstaining</strong> from <strong>sexual activity</strong> during these times is crucial to <strong>prevent spread</strong> to <strong>partners.</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13543.jpg\" alt=\"\" width=\"500\" height=\"252\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of Genital warts:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Imiquimod and podophyllotoxin&nbsp;</strong>are the primary drugs recommended as <strong>first-line treatments for genital warts. </strong>Imiquimod stimulates <strong>toll-like receptors 7 and 8</strong>, inducing <strong>apoptosis</strong> in <strong>macrophages,</strong> <strong>monocytes, and dendritic cells.</strong></span></li><li><span style=\"font-size:12.0pt;\">Imiquimod cream is approved for the treatment of actinic keratoses, <strong>superficial basal cell carcinoma</strong>, and <strong>genital warts</strong> through topical immunomodulation</span></li><li><span style=\"font-size:12.0pt;\">The <strong>most effective method </strong>to <strong>prevent</strong> the <strong>transmission </strong>of infection is to <strong>abstain from sexual intercourse when active lesions are present</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-132947.png\" alt=\"\" width=\"1000\" height=\"411\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Give continuous prophylaxis to the patient.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is not the correct approach because continuous prophylaxis with antivirals is <strong>not typically recommended </strong>for genital warts, which are caused by the <strong>human papillomavirus (HPV).</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Antivirals&nbsp;</strong>are more commonly used for other viral infections like <strong>herpes simplex </strong>virus.</span></li><li><span style=\"font-size:12.0pt;\">Moreover, prophylaxis doesn't prevent the transmission of HPV during periods without active lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Give prophylactic antivirals to the husband.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This option is incorrect for similar reasons as option A. <strong>HPV</strong>, the virus causing genital warts, does <strong>not</strong> have a <strong>prophylactic antiviral treatment</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Furthermore, since the <strong>husband</strong> does <strong>not</strong> have <strong>active lesions</strong> or a <strong>history</strong> of genital warts, <strong>prophylactic</strong> treatment is <strong>not indicated</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Give antivirals whenever active lesions are present.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">While this might seem like a reasonable approach, it is important to note that antivirals are not effective against HPV.</span></li><li><span style=\"font-size:12.0pt;\">Treatment for active genital warts typically involves <strong>topical agents</strong> or procedures like <strong>cryotherapy</strong>, <strong>not systemic</strong> antiviral medications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To prevent the transmission of genital warts caused by <strong>HPV</strong>, it is advisable to <strong>avoid sexual intercourse</strong> when <strong>active lesions</strong> are present, as there are <strong>no effective antiviral prophylaxis options</strong> for HPV, and HPV transmission risk is <strong>highest during periods</strong> with <strong>active lesions.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition - Volume I Chapter 25 Page no 25.43</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Illustrated synopsis of dermatology &amp; sexually transmitted diseases page no 318</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Robbins &amp; Cotran Pathologic basis of disease, 10 E page no 998</strong></span></p>",
      "correct_choice_id": 40313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9813,
      "choices": [
        {
          "id": 39219,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hemangioblastoma</span></span></span></p>"
        },
        {
          "id": 39220,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
        },
        {
          "id": 39221,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
        },
        {
          "id": 39222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroblastoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are small round blue cell tumors except: (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q2026209",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281383,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hemangioblastoma</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is not a small round blue cell tumor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Many childhood tumors have been collectively referred to as small round blue cell tumors due to their primitive histologic appearance. </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The differential diagnosis of such tumors includes neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, Ewing sarcoma/primitive neuroectodermal tumor, medulloblastoma and retinoblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Ewing&#39;s sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing&#39;s sarcoma is a classic example of a small round blue cell tumor. It is a highly malignant tumor that primarily affects bone and soft tissues, particularly in children and young adults.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a small round blue cell tumor of the eye, commonly seen in children. It is characterized by the presence of small, undifferentiated cells with hyperchromatic nuclei.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Neuroblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Neuroblastoma is another example of a small round blue cell tumor. It arises from neural crest cells and is most commonly found in the adrenal glands or along the sympathetic chain.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is <strong>not</strong> classified as a small round blue cell tumor, unlike Ewing&#39;s sarcoma, retinoblastoma, and neuroblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and cotrans pathologic basis of disease 8<sup>th</sup> edition pg 882</span></strong></span></span></p>",
      "correct_choice_id": 39219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9966,
      "choices": [
        {
          "id": 39830,
          "text": "<p><span style=\"font-size:12.0pt;\">Esophagitis</span></p>"
        },
        {
          "id": 39831,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 39832,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 39833,
          "text": "<p><span style=\"font-size:12.0pt;\">Barrett's esophagus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with heartburn and increased salivation. Upper gastrointestinal endoscopy was done, and the biopsy result is shown below. What is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/43.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p>",
      "unique_key": "Q3061073",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281384,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Barrett’s esophagus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This image indicates the diagnostic features of Barrett's esophagus. Note the transition between esophageal squamous mucosa and Barrett metaplasia, with abundant metaplastic goblet cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-170620.png\" alt=\"\" width=\"300\" height=\"239\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a complication of chronic gastroesophageal reflux disease (GERD) characterized by intestinal metaplasia within the esophageal squamous mucosa. It is a premalignant condition that confers an increased risk of esophageal adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, patients diagnosed with Barrett's Esophagus require that periodic endoscopy with biopsy, for detection of dysplasia every 1-2 years to detect dysplasias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of dysplasia is associated with prolonged symptoms, longer segment length, increased patient age, and Caucasian</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/45.jpg\" alt=\"\" width=\"542\" height=\"475\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Esophagitis:</strong> While esophagitis, inflammation of the esophagus, may be seen in GERD, it does not show the characteristic intestinal metaplasia with goblet cells as seen in Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Squamous cell carcinoma:</strong> This type of cancer originates from the squamous cells of the esophagus and does not involve the metaplastic changes characteristic of Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Adenocarcinoma:</strong> Adenocarcinoma of the esophagus can develop from Barrett's esophagus, but the histological image provided is more consistent with the premalignant stage of Barrett's esophagus rather than adenocarcinoma itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a premalignant condition marked by intestinal metaplasia with goblet cells within the esophageal squamous mucosa, requiring regular surveillance for dysplasia and potential progression to adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1464</strong></span></p>",
      "correct_choice_id": 39833,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9883,
      "choices": [
        {
          "id": 39498,
          "text": "<p><span style=\"font-size:12.0pt;\">IHC</span></p>"
        },
        {
          "id": 39499,
          "text": "<p><span style=\"font-size:12.0pt;\">Frozen section</span></p>"
        },
        {
          "id": 39500,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid paraffin</span></p>"
        },
        {
          "id": 39501,
          "text": "<p><span style=\"font-size:12.0pt;\">Formalin fixed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which fixation technique is used for fat in the histopathological examination? (AIIMS NOV 2020)</span></p>",
      "unique_key": "Q4176104",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281385,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Frozen section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Identification of neutral lipids and fatty acids in smears and tissues may require fresh smears or sometimes cryostat sections of tissue.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapid freezing makes the tissue sample firmer and ice acts as an embedding media allowing the tissue to be sectioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryostat machine temperature ranges from 0°C to -35°C. Most of the tissue can be sectioned between -15°C to -25°C. Tissue samples with high water content can be sectioned at a higher temperature. The tissues with high fat content are cut at a lower temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The stain used for fat is the oil red O stain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>It is used in the following conditions:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fat emboli in lung tissue</span></li><li><span style=\"font-size:12.0pt;\">Renal cell carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Sebaceous gland tumors of the skin</span></li><li><span style=\"font-size:12.0pt;\">Lipid-rich carcinomas</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IHC (Immunohistochemistry):</strong> This technique is used for detecting specific proteins within tissue sections but is not specifically used for fat preservation or visualization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Liquid paraffin:</strong> Liquid paraffin is most commonly used for the fixation technique in the histopathological examination. It involves the fixation of tissues using formalin and subsequent embedding in paraffin wax. This technique allows for long-term preservation of tissue morphology and cellular details, making it the standard preservation procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Formalin fixed:</strong> Formalin fixation is the standard method for preserving general tissue morphology but is not ideal for fat preservation, as it can dissolve lipid content.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alcoholic formalin is the most commonly used fixation technique for preserving and examining fat in histopathological sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Liquid paraffin is the most commonly used embedding agent.</span></p>",
      "correct_choice_id": 39499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20829,
      "choices": [
        {
          "id": 83280,
          "text": "<p><span style=\"font-size:12.0pt;\">Leishmania tropica</span></p>"
        },
        {
          "id": 83281,
          "text": "<p><span style=\"font-size:12.0pt;\">Babesia</span></p>"
        },
        {
          "id": 83282,
          "text": "<p><span style=\"font-size:12.0pt;\">Trypanosoma</span></p>"
        },
        {
          "id": 83283,
          "text": "<p><span style=\"font-size:12.0pt;\">Histoplasma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A lady from West Rajasthan presented with an ulcer surrounded by erythema on the right leg. Microscopy of the biopsy from the edge of the ulcer showed organisms with dark staining nuclei and kinetoplast. What is the most likely causative agent? (NEET PG 2023)</span></p>",
      "unique_key": "Q2877687",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281386,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Leishmania tropica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above clinical vignette is suggestive of cutaneous leishmaniasis, caused by Leishmania tropica</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture25.jpg\" alt=\"\" width=\"1000\" height=\"459\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Difference between Leishmania tropica and donovani is that tropica do not invade organs. It causes cutaneous leishmaniasis otherwise called as Delhi boil, Aleppo boil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following image shows an<strong> ulcer surrounded by erythema</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture26.jpg\" alt=\"\" width=\"283\" height=\"248\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, it is endemic to Bihar, West Bengal, Jharkhand, and Uttar Pradesh.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image given below shows a phlebotomus sandfly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/picture27.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LIFE CYCLE IS GIVEN OF FILARIA:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture10001.png\" width=\"3128\" height=\"2261\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Babesia&nbsp;</strong>causes babesiosis, a tick-borne disease, presents as a malaria-like illness with fever, chills, and hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Trypanosoma </strong>cause diseases like African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease), presents with different clinical features, such as fever, swollen lymph nodes, and neurological symptoms in African trypanosomiasis while in Chagas disease, fever and swelling at the infection site, and cardiomyopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Histoplasma&nbsp;</strong>(dimorphic fungus) causes histoplasmosis. Mostly affects the lungs and then can disseminate to other organs in immunocompromised individuals. Presents variably, but it does not typically cause an ulcer with erythema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leishmania tropica is the causative agent of cutaneous leishmaniasis, leading to skin ulcers that can be identified by microscopy showing organisms with kinetoplasts. Awareness of this condition is crucial for correct diagnosis and management, particularly in endemic areas like parts of Rajasthan, India.</span></p>",
      "correct_choice_id": 83280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9801,
      "choices": [
        {
          "id": 39171,
          "text": "<p><span style=\"font-size:12.0pt;\">TdT</span></p>"
        },
        {
          "id": 39172,
          "text": "<p><span style=\"font-size:12.0pt;\">CD1a</span></p>"
        },
        {
          "id": 39173,
          "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
        },
        {
          "id": 39174,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytokeratin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not usually involved in the immunohistochemistry of acute lymphoblastic leukemia? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q1379460",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281387,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Cytokeratin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytokeratin is not a marker of acute lymphoblastic leukemia (ALL). It is an epithelial cell marker for thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immunophenotype in ALL –</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Terminal deoxynucleotidyl-transferase (TdT), a specialized DNA polymerase, is positive in more than 95% of cases.</span></li><li><span style=\"font-size:12.0pt;\">Lymphoblasts usually express the pan B-cell marker CD19 and the transcription factor PAX5, as well as CD10.</span></li><li><span style=\"font-size:12.0pt;\">More mature “late pre-B” ALLs express CD10, CD19, CD20, and cytoplasmic IgM heavy chain (μ chain).</span></li><li><span style=\"font-size:12.0pt;\">T-ALLs are arrested at various stages of pre-T cell development. In most cases the cells are positive for CD1, CD2, CD5, and CD7.</span></li><li><span style=\"font-size:12.0pt;\">“Late” pre-T cell tumors are positive CD3, CD4, and CD8</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-184729.png\" alt=\"\" width=\"1000\" height=\"380\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. TdT</strong>: A highly specific marker for ALL, present in over 95% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. CD1a</strong>: Commonly expressed in T-ALL, particularly in early T-cell development stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. CD3</strong>: A marker for T-cell lineage, used in identifying T-ALL and distinguishing it from B-cell lineage ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cytokeratin&nbsp;</strong>is not a marker for <strong>acute lymphoblastic leukemia (ALL)</strong> and is instead an epithelial cell marker used in identifying epithelial tumors such as thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Pg 111</strong></span></p>",
      "correct_choice_id": 39174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10425,
      "choices": [
        {
          "id": 41666,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunophenotyping</span></span></span></p>"
        },
        {
          "id": 41667,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LAP score</span></span></span></p>"
        },
        {
          "id": 41668,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FISH and PCR</span></span></span></p>"
        },
        {
          "id": 41669,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flow cytometry</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male patient presents with a complaint of fatigue persisting for the past year, accompanied by massive splenomegaly. A comprehensive blood workup has been performed, revealing several notable findings. The patient exhibits anemia and a significantly elevated total leukocyte count of 50,000/microL. Further analysis of the peripheral blood smear shows the presence of neutrophils (60%), basophils (4%), eosinophils, and myoblasts, myelocytes, and metamyelocytes. Additionally, the myeloid to erythroid ratio is found to be 18:1. Which investigation would be the most sensitive for further evaluation in this case: </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
      "unique_key": "Q4221302",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281388,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) FISH and PCR </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical picture of fatigue, splenomegaly, and peripheral blood smear findings suggest chronic myelogenous leukemia (CML). Fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR) tests are used to detect the BCR-ABL gene, which is specific for CML.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic myelogenous leukemia (CML) is a myeloproliferative disorder that most commonly affects people in their fifth to sixth decade of life. A reciprocal (9;22) (g34;g11) translocation results in the creation of the chimeric BC-ABL gene (Philadelphia chromosome). This BCR-ABL gene differentiates ML from other myeloproliferative disorders and can be detected using fluorescent in situ hybridization (FISH) or polymerase chain reaction (PCR) .</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical characteristics:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mild to moderate anemia and hypermetabolism, fatigability, weakness, weight loss, and anorexia. Dragging sensation in the abdomen caused by splenomegaly, or the acute onset of left upper quadrant pain due to splenic infarction. The spleen is often greatly enlarged as a result of extensive extramedullary hematopoiesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Extramedullary hematopoiesis can also produce mild hepatomegaly and lymphadenopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral blood</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe leukocytosis with a leukocyte count that frequently exceeds 100,000 cells/mm, primarily composed of neutrophils, band forms, metamyelocytes, myelocytes, eosinophils, and basophils.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Moderate normocytic normochromic anemia - Rising basophilia indicates impending blastic transformation.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The accelerated phase is defined as an increasing degree of anaemia, a blast count in blood or marrow of 10-20%, a marrow basophil count of 20% or more, and a platelet count of less than 100,000/l.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blastic phase or blast crisis in CML satisfies the definition of acute leukemia by having more than 20% blood or marrow blasts.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemia of moderate severity - A rising basophilia is indicative of impending blastic transformation. - The accelerated phase is defined as an increasing degree of anaemia, a blast count in blood or marrow of 10-20%, a marrow basophil count of 20% or more, and a platelet count of less than 100,000/l.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A blast phase or blast crisis in CML meets the definition of acute leukemia by having blood or marrow blasts of more than 20%.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/5_iKbgTlq.jpg\" style=\"height:237px; width:300px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture10.jpg\" style=\"height:217px; width:300px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Immunophenotyping:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Used for the diagnosis of various hematologic malignancies, particularly lymphoid neoplasms. It is less specific for CML.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp; B. LAP score (Leukocyte Alkaline Phosphatase):&nbsp;</span></strong><span style=\"font-size:12.0pt\">The LAP score is typically low in CML, but this test is less specific and has largely been replaced by molecular diagnostic techniques like FISH and PCR.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Flow cytometry:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Useful for identifying and classifying hematologic malignancies based on cell surface markers but is not the most specific test for detecting the BCR-ABL fusion gene in CML.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) are the most sensitive investigations for detecting the BCR-ABL fusion gene, the hallmark of chronic myelogenous leukemia (CML). These tests are crucial for accurate diagnosis and monitoring of CML.</span></span></span></p>",
      "correct_choice_id": 41668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56829,
      "choices": [
        {
          "id": 226709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Measurement of erythropoietin levels</span></span></span></p>"
        },
        {
          "id": 226710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Bone marrow biopsy</span></span></span></p>"
        },
        {
          "id": 226711,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Genetic testing for JAK2 mutation</span></span></span></p>"
        },
        {
          "id": 226712,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest X-ray</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 12-year-old boy from a high-altitude village presents to the emergency department with a high fever, weakness, and fatigue. He has been living at high altitudes all his life. His physical examination reveals a flushed face, mild splenomegaly, and no signs of cyanosis. Laboratory results show a hemoglobin level of 17 g/dL, a total leukocyte count of 21,000, with differential showing 25% neutrophils, 30% lymphocytes, 5% eosinophils, and 40% immature myeloid cells, including myelocytes and metamyelocytes. Given these findings, what should be the next step in the investigation?</span></span></span></p>",
      "unique_key": "Q7711385",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: A. Measurement of erythropoietin levels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The clinical scenario suggests polycythemia, characterized by elevated hemoglobin levels (&gt;16 g/dL). The next step should be to measure erythropoietin levels, which helps distinguish between primary and secondary forms of polycythemia. Polycythemia vera (PCV), a primary form of polycythemia, typically shows low erythropoietin levels due to autonomous production of red blood cells driven by JAK2 mutations. In contrast, secondary forms, often seen in high-altitude residents or those with erythropoietin-secreting tumors, present with elevated erythropoietin levels. Evaluating erythropoietin levels helps guide further testing and management, including differentiating between PCV and other causes of absolute polycythemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option B. Bone marrow biopsy</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A bone marrow biopsy may be considered later but is not the initial step. It is typically used to confirm PCV by showing panmyelosis, particularly increased red cell production, but the first step should be to evaluate erythropoietin levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option C. Genetic testing for JAK2 mutation</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Testing for JAK2 mutations is crucial for diagnosing PCV, but it should follow erythropoietin level testing. Low erythropoietin levels would prompt JAK2 testing to confirm PCV, whereas high levels would indicate secondary causes, making JAK2 testing less relevant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Option D. Chest X-ray</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A chest X-ray would not provide specific information relevant to polycythemia. It might be useful if lung disease was suspected as a secondary cause of polycythemia, but in this context, it is not the immediate next step.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">In the evaluation of polycythemia, measuring erythropoietin levels is essential to differentiate primary causes like polycythemia vera, which shows low erythropoietin, from secondary causes with elevated erythropoietin levels. This initial step guides further diagnostic evaluation and management, including the consideration of genetic testing for JAK2 mutations in suspected cases of polycythemia vera.</span></span></span></p>",
      "correct_choice_id": 226709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31886,
      "choices": [
        {
          "id": 127414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herpes simplex virus</span></span></span></p>"
        },
        {
          "id": 127415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ebstein Barr virus</span></span></span></p>"
        },
        {
          "id": 127416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cytomegalovirus</span></span></span></p>"
        },
        {
          "id": 127417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HIV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient underwent a renal transplant following which he developed an infection that had owl eye inclusions. What is the likely cause of the finding? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q8061467",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281430,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Cytomegalovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of owl eye inclusions in a patient with a history of immunosuppression (such as following a renal transplant) is highly suggestive of cytomegalovirus (CMV) infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cytomegalovirus (CMV):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pathology:</span></strong><span style=\"font-size:12.0pt\"> CMV is a member of the herpesvirus family and is a common cause of infection in immunocompromised individuals. The virus causes the formation of characteristic intranuclear inclusions that resemble owl&#39;s eyes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Features:</span></strong><span style=\"font-size:12.0pt\"> Patients may present with fever, fatigue, and signs of organ-specific involvement, such as pneumonitis, hepatitis, or retinitis, depending on the site of infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Histopathology:</span></strong><span style=\"font-size:12.0pt\"> The characteristic finding on histopathology is the presence of large cells with basophilic intranuclear inclusions surrounded by a clear halo, giving the appearance of owl&#39;s eyes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Herpes simplex virus:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Typically causes vesicular lesions and does not produce owl eye inclusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Epstein Barr virus:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Associated with infectious mononucleosis and various lymphoproliferative disorders, not typically owl eye inclusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. HIV:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Causes immunosuppression but does not produce characteristic owl eye inclusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Owl eye inclusions seen in immunocompromised patients, especially post-transplant, are indicative of cytomegalovirus (CMV) infection.</span></span></span></p>",
      "correct_choice_id": 127416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9837,
      "choices": [
        {
          "id": 39315,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be started within 4 hours of receiving it from the blood bank.</span></p>"
        },
        {
          "id": 39316,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 4 hours of receiving from the blood bank.</span></p>"
        },
        {
          "id": 39317,
          "text": "<p><span style=\"font-size:12.0pt;\">No such time restraint and can be done anytime.</span></p>"
        },
        {
          "id": 39318,
          "text": "<p><span style=\"font-size:12.0pt;\">It should be completed within 6 hours of receiving from the blood bank.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is correct regarding transfusion of the blood received from blood bank? </span>(AIIMS MAY 2018)</p>",
      "unique_key": "Q8193938",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281431,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) It should be completed within 4 hours of receiving from the blood bank.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blood received from blood bank should be completely transfused within 4 hours of receiving.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Principles of blood administration:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">All blood products should be given through an appropriate blood administration set containing a filter.</span></li><li><span style=\"font-size:12.0pt;\">A careful aseptic technique should be practiced at all times.</span></li><li><span style=\"font-size:12.0pt;\">Vital signs should be documented before and after transfusion and as clinically required. For the first 15 minutes after the infusion has begun, the patient should be kept under close observation to detect any signs of a serious transfusion reaction. If none is observed, the infusion rate may be increased.</span></li><li><span style=\"font-size:12.0pt;\">One unit of red cells is often given in 1 to 4 hours, depending on the amount to be transfused and on the patient's cardiovascular status. <strong>Infusion of a unit for longer than 4 hours is not recommended, as there is a risk of bacterial proliferation because the opened unit is at room temperature.</strong></span></li><li><span style=\"font-size:12.0pt;\">No other solution and no medication should be added to or infused through the same tubing as a blood product.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ringer's lactate or other solutions containing calcium must never be added to a blood product because the calcium present leads to coagulation</strong>.</span></li><li><span style=\"font-size:12.0pt;\">After the transfusion has been completed, the transfusion tag or record should become part of the patient's chart.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It should be started within 4 hours of receiving it from the blood bank</strong>: This option is incorrect as the emphasis is on completing the transfusion within 4 hours, not just starting it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. No such time restraint and can be done anytime</strong>: This is incorrect, as there is a specific time frame to prevent bacterial proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It should be completed within 6 hours of receiving from the blood bank</strong>: This option is incorrect; the recommended maximum time for completion is 4 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Blood transfusions must be completed within 4 hours of receiving the blood from the blood bank</strong> to minimize the risk of bacterial proliferation and ensure patient safety.</span></p>",
      "correct_choice_id": 39316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10461,
      "choices": [
        {
          "id": 41810,
          "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interstitial cystitis</span></span></span></p>"
        },
        {
          "id": 41811,
          "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malakoplakia</span></span></span></p>"
        },
        {
          "id": 41812,
          "text": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polypoid cystitis</span></span></span></p>"
        },
        {
          "id": 41813,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute cystitis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient underwent cystoscopy, which showed multiple yellow-white plaques in the trigone of the bladder. The histopathology image is given below. What is the diagnosis? (NEET PG 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-475.jpg\" style=\"height:288px; width:400px\" /></p>",
      "unique_key": "Q4349706",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281432,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Malakoplakia </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The cystoscopy findings of multiple yellow-white plaques in the bladder trigone and histopathology image showing Michaelis-Gutmann bodies are consistent with malakoplakia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malakoplakia is a rare condition of unknown etiology primarily affecting the urinary bladder. It is likely associated with chronic inflammation and defective phagocytosis by macrophages. It is more commonly observed in immunocompromised patients and transplant recipients.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">On cystoscopy, malakoplakia appears as multiple yellow-white plaques in the bladder trigone. The lesions are soft, flat, and slightly raised, with sizes ranging from 0.5 to 5 cm.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histopathologically, malakoplakia shows massive accumulation of foamy macrophages, multinucleate giant cells, and lymphocytes.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foamy macrophages contain granular cytoplasm that is PAS-positive.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Michaelis-Gutmann bodies, characterized by cytoplasmic laminated concretions of calcium phosphate, are seen within macrophages.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Michaelis-Gutmann bodies represent lysosomes filled with partially digested debris of bacteria, resulting from defective phagocytosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-144703.png\" style=\"height:223px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Interstitial cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interstitial cystitis is a chronic condition causing bladder pain and frequent, urgent urination. It does not present with yellow-white plaques or Michaelis-Gutmann bodies.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Polypoid cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polypoid cystitis presents with polypoid or papillary projections in the bladder, often due to chronic irritation, such as long-term catheter use. It does not show the specific histopathological features of malakoplakia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acute cystitis</span></strong><span style=\"font-size:12.0pt\">: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute cystitis is an infection of the bladder characterized by symptoms such as dysuria, frequency, and urgency of urination. The cystoscopy findings would typically show an inflamed, red mucosa, not yellow-white plaques.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-4px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malakoplakia is characterized by multiple yellow-white plaques in the bladder trigone, as seen on cystoscopy, and histopathological findings of foamy macrophages with PAS-positive cytoplasm and Michaelis-Gutmann bodies. This condition is associated with chronic inflammation and defective phagocytosis, commonly affecting immunocompromised patients.</span></span></span></p>",
      "correct_choice_id": 41811,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24746,
      "choices": [
        {
          "id": 98945,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal dominant</span></span></span></p>"
        },
        {
          "id": 98946,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal recessive</span></span></span></p>"
        },
        {
          "id": 98947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudodominant inheritance</span></span></span></p>"
        },
        {
          "id": 98948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete penetrance</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mode of inheritance from the pedigree chart given below:</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256107.jpg\" style=\"height:273px; width:400px\" /></span></span></p>",
      "unique_key": "Q2851521",
      "question_audio": null,
      "question_video": null,
      "map_id": 12281433,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Autosomal dominant </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The pedigree chart given is suggestive of an autosomal dominant Disorders</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256108.jpg\" style=\"height:197px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autosomal dominant inheritance is characterized by a consistent appearance of affected individuals in every generation, with no sex bias and manifestation in individuals who carry one copy of the mutant allele.</span></span></span></p>",
      "correct_choice_id": 98945,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}